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Outline of the thesis
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Public health and infectious diseases
Biomaterial associated infections
Between the year 2000 and 2050 the percentage of people over the age of 60 
worldwide is expected to rise from 11% to 22%. The total number of this population 
is estimated to grow to 2 billion in this same period. Eighty percent of these older 
people will live in low and middle income countries. This particular group of in low and 
middle income countries will have a 3 times higher chance of lower quality of life due to 
noncommunicable diseases such as cancer, diabetes, osteoporosis and heart diseases 
[1-5]. This group of rather vulnerable people will probably receive medical treatment 
once or more in their old age. With many procedures patients will get in contact with 
biomaterials, ranging from infusion needles to implants, such as pacemakers or artificial 
joints. These biomaterials as shown in Figure 1 are often associated with infections 
by the skin bacterium Staphylococcus epidermidis [6-12]. Additionally, infections with 
(multi-drug resistant) Staphylococcus aureus strains are a common problem in hospitals. 
The first publications about biomaterial-associated infections (BAI) go back to the early 
1950’s by Elek et al. [13]. They discovered higher infection rates of S. aureus inoculum 
on a soaked suture wire compared to standard inoculum in human volunteers. In more 
recent studies, the percentages of infection related to implantation are approximately 
between 1.2 and 53% [14-18]. Since materials are being implanted daily in many 
patients worldwide as shown in Table 1, the total number of resulting infections is very 
large. There would not be a problem if these infections were easy to treat, however 
Figure 1: Overview of commonly implanted 
biomaterials and medical devices. This figure 
illustrated the variety of medical implants 
being used these days.
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S. epidermidis will adhere to the implanted material where it forms a biofilm. From 
there it will also infect the surrounding tissue and host cells, even after the material 
has been removed as has been shown in mice [10, 19]. This makes treatment of BAI 
more difficult, since some antibiotics like vancomycin cannot penetrate the infected 
tissue efficiently [20]. This can result in many complications with in the worst case 
scenario the necessity of the chirurgical removal of the implant. To prevent BAI we 
hope to find new molecular factors that could help understand how bacteria growing at 
or near implanted materials interact with the host. Although most research regarding 
BAI is performed with mammalian models such as mice or goats [21, 22], we used the 
zebrafish larvae as model as described in more detail below.
Tuberculosis and the link with metabolic syndromes
An infectious disease not related with biomaterials but forming another major societal 
problem is tuberculosis (TB), which is caused by Mycobacterium tuberculosis (Mtb). 
Mtb is one of the most successful human pathogens and is capable of establishing 
infection despite the host innate and adaptive immune responses. Each year 9 
million people develop TB and over 1,5 million die from it. A third of the global 
human population is estimated to be latently infected, and has a 5-10% lifetime risk 
of developing TB reactivation disease [24]. Therefore finding better treatments and 
diagnostic tools for this disease is essential. With the upcoming antibiotic resistance 
for the first line antibiotics including Isoniazid (1952), Rifampicin (1966), Pyrazinamide 
(1952) and Ethambutol (1961), there is a great need for new antibiotics [25]. The World 




Average cost per 
procedure 
1 Artificial eye lenses 2.582 million $8-10 billion $3.200-4.500 
2 Ear tubes 715.000 $1-2 billion $1.000-4.500 
3 Coronary stents 560.000 $7,5 billion $13.000 
4 Artificial knees 543.000 $12 billion $22.000 
5 Metal pins, screws, plates 
and rods 
453.000 $4,5 billion $2.000-20.000 
6 Intra-Uterine Devices 425.000 $340 million $800 
7 Spine screws, rods and 
artificial discs 
413.000 $10 million $25.000 
8 Breast implants 366.000 $992 million $3.351 
9 Pacemakers 235.567 $4,5 billion $20.000 
10 Artificial hips 230.000 $10,5 billion $45.000 
11 Implantable Cardioverter 
Defibrillators 
133.262 $5,5 billion $40.000 




Health Organization (WHO) reported that already over 300.000 people were reported 
with multi drug-resistant tuberculosis (MDR-TB) in 2013. Extensively drug-resistant 
tuberculosis (XDR-TB), bacteria are resistant also to second line drugs, and has been 
reported by 100 countries in 2013. It is estimated that 9% of the people diagnosed with 
MDR-TB have in fact XDR-TB [26]. 
Although in vitro models can provide detailed information of how TB bacteria are taken 
up and survive in macrophages, it does not reflect the infection in vivo. Unfortunately 
mice have limitations as a model to study the pathogenesis of TB, since they do not 
form the characteristic granulomas with necrotic centres after infection. Guinea pigs 
and rabbits do show the granuloma formation, however they are relatively expensive 
and do not allow advanced genetic approaches, real time imaging or high-throughput 
screening. The zebrafish larvae infection system (this thesis) can with the use of the 
natural pathogen M. marinum, a close relative of Mtb, model the early steps in human 
TB disease progression very well. After infection of zebrafish embryos with mycobacteria 
the innate immune cells will form granulomas, with in later stages of development 
also the formation of necrotic centres [27]. As outlined below zebrafish larvae allow 
the use of advanced genetic and real time imaging technologies and are excellently 
suited for high-throughput screening.       
Although TB is already a major health issue and difficult to treat, it becomes more 
problematic when people are also infected with the human immunodeficiency virus 
(HIV) [28]. The WHO estimated that people have a 26 to 31 times higher change to 
develop TB when already diagnosed with HIV [29].     
Unfortunately not only HIV is a great risk in combination with TB, also obesity is linked 
to TB [30-32]. Obesity and overweight are defined as abnormal fat accumulation which 
is a great health risk. It is also a large risk factor for example for diabetes, cardiovascular 
diseases and cancer [33, 34]. Although commonly perceived as a problem in high income 
countries, its incidence is now also rising in low- and middle-income countries. In 2008 
more than 1.4 billion adults globally were overweight and more than half a billion 
were obese. Obesity among children is ever so problematic since already 42 million 
children worldwide are overweight who will likely become obese adults, and are more 
susceptible to diabetes and cardiovascular diseases [35]. Many treatments are known, 
however, due to ethnic backgrounds and different lifestyles globally, it is a challenge 
to develop new strategies to prevent obesity [36].     
A particular gene that regulates appetite, called leptin, has been well described in the 
context of metabolic processes [37] and also functions in immunity and inflammation 
[38, 39]. Overnutrition and obesity are correlated with high concentrations of leptin. 
Having high levels of leptin can lead to leptin resistance. This in turn can lead to 
increased TNF-α production, altered T cell subset ratios and repressed T cell response 
[40], with as a result, higher incidence of infectious diseases. This suggests that leptin 
resistance would be disadvantageous in the context of TB treatment, and there are 
scientific papers that could confirm this statement [41, 42]. However there are also 
few papers indicating the opposite, that there is a positive effect on TB progression due 
13
1
to obesity [43]. The role of leptin has been described in the context of TB and obesity 
[30] but clear evidence that obesity as a result of leptin resistance could lower the 
progression of TB has not been found yet. 
Zebrafish as a model for innate immunity research of human 
diseases
The zebrafish finds it origin in the Himalayan region and it is a popular aquarium 
fish. The first scientific experiments with this organism date from the early 1970’s by 
Dr. George Streisinger [29], who used it for studies of vertebrate development and 
genetics. Since then it showed to be a versatile model for studies of human diseases 
such as cancer, infectious diseases, cardiovascular disease, diabetes, haematopoiesis, 
and neural disorders [44-46]. Although zebrafish do not have lungs and are cold 
blooded they have high similarity with mammalians from a genetic and developmental 
perspective. Since the larvae are very small and transparent, they are easy to follow in 
time, also due their fast development. The first innate immune cells are present at 1 
day post fertilization (dpf). One adult couple can produce up to 300 eggs per week and 
the larvae are therefore very well suited for high-throughput screens. The availability 
of many mutant and transgenic strains makes it possible for example to follow live 
fluorescently labelled macrophages or neutrophils interact with fluorescently labelled 
pathogens inside a larva. Because they are so small, housing costs per animal are low. 
Many tools are available to identify genes involved in specific biological processes, 
such as random mutagenesis or targeted mutagenesis using zinc-finger nucleases or 
the CRISPR-Cas system [47, 48]. Also, using a morpholino approach, which is a ~25 
base artificial oligonucleotide, injected into the one cell stage, specific gene function 
can be knocked down for the first couple of days of embryonic development [49, 50]. 
Altogether, this has led to the common use of zebrafish larvae in biomedical research. In 
addition, the model is better suited for translational studies than invertebrate animals 
since over 80% of genes linked with human disease have at least one obvious zebrafish 
orthologue [51]. Therefore it holds a very strong position as a screening model with 
a high-throughput level in between cell and tissue culture systems and higher animal 
models.
Outline of the thesis 
The work described in this thesis focusses on the establishment and improvement of 
automated and high-throughput techniques for immunological studies in zebrafish 
larvae. We studied the innate immune host response towards S. epidermidis, a 
normally innocent human skin bacterium that is one of the main causes of biomaterial-
associated infections. To this end, we used transcriptome analysis tools such as micro-
arrays and RNA deep sequencing (RNAseq). To compare the results of infection with S. 
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epidermidis with the response to a natural fish pathogen, we performed simultaneously 
experiments with M. marinum.
Chapter 2 describes a broad overview of all the applications of injecting automatically 
with a robotic micro-injector. These include the generation of transgenic animals by 
injecting DNA into the yolk of a one-cell stage fertilized egg, or the knockdown of 
particular genes by injection of morpholinos. Furthermore, injections of opportunistic 
or pathogenic bacteria as well human cancer cells are described in detail. Analyses of 
the large amounts of injected eggs are performed with either automated confocal laser 
scanning microscopy (CLSM) or high-throughput Complex Object Parametric Analysis 
and Sorting (COPAS XL). 
Continuing on chapter 2 we optimized our high-throughput screening system using 
video recorded procedures as shown in chapter 3. Here we show in detail how multiple 
devices such as a large spawning tank, an automated micro-injector, a COPAS flow-
cytometer, and a Vertebrate Automated Screening Technology (VAST BioImager) can 
yield a combination of a high-throughput low-resolution with a medium-throughput 
high-resolution screening technology. Furthermore we optimized the injection method 
by selecting the best developmental stage for early yolk injections with S. epidermidis 
and a highly and medium virulent M. marinum strain. 
Chapter 4 is focused on the pathogenesis of S. epidermidis in zebrafish larvae. This was 
the first scientific report of injecting S. epidermidis into zebrafish larvae. We performed 
extensive imaging and automated the monitoring of bacterial burden progression in live 
larvae using the COPAS XL. It was found that injection of S. epidermidis into the caudal 
vein did not lead to an infection, however when injected into the yolk of a 16-128 cell 
stage embryo, we did manage to reproducibly create an infection spreading into the 
entire body of the larvae. Time course analysis of transcriptome host responses was 
performed using micro-arrays. This led to the discovery of a group of host genes that 
were differentially expressed after infection by S. epidermidis and not by M. marinum. 
The validation of the micro-array results was performed using a newer technique, the so 
called RNAseq. Since transcriptome analysis using micro-arrays and RNAseq can provide 
a lot of information on how the host reacts to an invasive agent such as a bacterium, it 
can reveal possible targets for new treatment strategies. 
Although the RNAseq method is very promising, the analysis still relies on expensive ‘black 
box’ software packages or dedicated programming skills of the researcher. However 
the second option could be rather difficult for a biologist untrained in informatics. 
In chapter 5 we describe the results of collaboration between bioinformaticians, 
statisticians and biologists. This led to a straight forward and easy to use software 
package called GeneTiles, for the analysis and visualization of large RNAseq datasets. 
15
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One of the main advantages is that is runs on a server with a user-friendly interface. 
This means that is can be accessed from computers with an internet connection and 
different operations systems such as Windows and Linux can be used. The implantation 
of additional software packages such as DEXSeq has led to the discovery of differentially 
expressed genes under infectious conditions. Also a direct visualization of the differential 
expression in a variety of biological pathways obtained from Wikipathways leads to a 
fast interpretation of functional data. 
In chapter 6 we present a time course analysis of the distribution of nanometer and 
micrometer sized polystyrene particles after zebrafish yolk injection. This could help 
us to develop a screening model for biomaterial-associated infection using zebrafish 
larvae. We determined the parameters for the diameter and shape of the particles 
that determine the possibility to inject these particles using glass micro capillaries into 
zebrafish larvae. The size is also very important for the distribution inside the larvae, 
since we found that the smaller sized particles spread more compared to the bigger 
particles. 
In chapter 7 the results are summarized and discussed in the context of possible 
applications of the results for biomedical purposes. 
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The increasing use of zebrafish larvae for biomedical research applications is resulting 
in versatile models for a variety of human diseases. These models exploit the optical 
transparency of zebrafish larvae and the availability of a large genetic tool box. Here 
we present detailed protocols for the robotic injection of zebrafish embryos at very 
high accuracy with a speed of up to 2000 embryos per hour. These protocols are 
benchmarked for several applications: (1) the injection of DNA for obtaining transgenic 
animals, (2) the injection of antisense morpholinos that can be used for gene knock-
down, (3) the injection of microbes for studying infectious disease, and (4) the injection 
of human cancer cells as a model for tumor progression. We show examples of how the 
injected embryos can be screened at high-throughput level using fluorescence analysis. 
Our methods open up new avenues for the use of zebrafish larvae for large compound 
screens in the search for new medicines. 
Introduction
The use of zebrafish as an animal model has an abundance of applications in fundamental 
research in vertebrate development, physiology and toxicology [1-5]. More recently, 
this model has also been shown to be highly applicable for studies of many types of 
disease [6-20]. The benefits of the relatively small and transparent larvae for optical 
imaging using transgenic fish lines expressing many colour varieties of the GFP protein 
have been widely exploited in these disease studies [6]. Currently the genetic tool 
box is comprised of a large variety of gene knock-down or knock-out systems [21-
28]. Additionally many genomic-based techniques such as RNA deep sequencing, 
metabolomics and proteomics have been applied to zebrafish [29-39]. A comparison of 
parallel deep RNA sequencing and proteome analysis has been reported (Palmblad et 
al., submitted). The fact that the innate immune system of zebrafish is highly similar to 
that of mammals and is already fully functional as early as two days after fertilization 
makes zebrafish larvae extremely useful for studies of diseases related to the immune 
system [40, 41]. Examples given below are studies of cancer progression and infectious 
diseases caused by many bacteria, fungi or viruses.
Zebrafish micro-injection and screening tools
Micro-injection of zebrafish embryos is an essential technology for the following 
applications:
• The generation of transgenic zebrafish lines.
• The generation of gene knock-out lines using zinc fingers or TALEN technology.
• Gene knock-down using morpholinos, siRNA or antibodies.
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• Overexpression of genes by injection of mRNA.
• The injection of tracer dyes or particles.
• Intraorganismal introduction of microbes in embryos or larvae for infection
 studies.
• Transplantation of cells between embryos.
• Xenograft implantation of cells for cancer studies.
Many general methods for these applications can be found in the book: Essential 
Zebrafish Methods: Cell and Developmental Biology [42]. More specifically for injection 
methods that can be used for these applications we can refer to detailed descriptions 
in four methodology compendia or books: (1) Zebrafish: Methods and Protocols [43], 
(2) The zebrafish book, A guide for the laboratory use of zebrafish (Danio rerio), 5th 
edition [44] and (3) Methods in Cell Biology issues 104 and 105 [45, 46], which provide 
comprehensive laboratory protocols and reviews for recent zebrafish methods related 
to disease models and chemical screens. Recently also video enhanced protocols 
for zebrafish micro-injection have been published, for instance by Benard et al. [47], 
describing in detail the application of micro-injection of bacterial pathogens. In brief, all 
methods use thin glass capillary needles to introduce compounds or biological materials 
inside various parts of embryos and larvae. In the embryonic and early larval stages the 
transparency and softness of the tissues warrants a high success rate of the injection 
protocol. In contrast, injection in the later larval stages is more difficult due to higher 
rigidity of tissue and can currently only be performed at relatively low-throughput. For 
the first four applications mentioned above, DNA, RNA or morpholinos can be injected 
into the yolk of early stage embryos. Due to the relatively large size of the yolk this offers 
a fast procedure for micro-injection that even can be completely automated. Robotic 
injection of zebrafish embryos using image recognition has been shown to accurately 
deliver morpholinos at a throughput level of 25 consecutive injections per run of 2 min 
[48]. Recently an alternative robotic injection method was shown to inject embryos at 
a speed of 2000 per hour with a success rate of 99% [49]. This method makes use of 
specially designed grids where embryos occupy the hemi-spherical wells of an agarose 
cast in a centred and completely reproducible manner, with the cell mass always resting 
to the side. In this paper we present further applications and detailed methods for the 
use of this robotic injection system. We will also provide examples of high-throughput 
screening of injected embryos. Screening of zebrafish embryos can make use of the 
rapid technical advances in high-throughput analysis methods for zebrafish embryos 
[6, 50, 51]. The COPAS XL (Complex Object Parametric Analyzer and Sorter) system 
(Union Biometrica) can be used for fluorescence imaging of zebrafish embryos at a 
throughput level of 200 embryos per minute. This system has been designed for the 
analysis, sorting and dispensing of objects up to 1.5 mm in diameter based on size, 
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optical density and fluorescence intensity. A profiler option simultaneously detects 
and analyzes up to 8000 data points per object for each of the channels of extinction 
and fluorescence, and includes advanced imaging options. The resulting profiles can 
be used to set parameters for zebrafish larvae to be sorted in 96-wells plates. In this 
paper we describe software to process the recorded data for further statistical analysis. 
Recently a Vertebrate Automated Screening Technology (VAST) with cellular-resolution 
and parallel animal processing has been reported in which the screening throughput 
is limited only by the image acquisition speed rather than by the fluidic or mechanical 
processes [52, 53]. In the near future we will also use this methodology for zebrafish 
high content image analysis aimed at disease screening at high-throughput such as 
discussed below.
Applications of micro-injection for studies of infectious disease
A growing list of pathogenic bacteria, filamentous fungi, yeasts, microsporidia, helminths, 
trypanosomes and viruses has been used for experimental infection studies in zebrafish, 
as detailed in several recent reviews [14, 18, 54-59]. Bacterial pathogens have been 
tested most frequently, as discussed by Meijer and Spaink [14] who present an overview 
of over 30 bacterial species for which disease studies in zebrafish have been published. 
In addition, zebrafish larvae have also been used to study the effects of a bacterial strain 
that normally do not cause a disease, Staphylococcus epidermidis, for the purpose of 
studying the effects of factors such as medical implant materials on defence mechanisms 
against commensal bacteria [39]. One of the most successful zebrafish disease models 
is the indirect study of human tuberculosis via the infection of zebrafish embryos with 
Mycobacterium marinum, as recently reviewed by Tobin, May and Wheeler [60]. The 
studies of M. marinum infection have already led to the clarification of many important 
processes in the life cycle of tuberculosis infection, in particular those underlying the 
mechanisms of granuloma formation in which the bacteria proliferate in macrophages 
[61, 62]. The context of the embryo’s developing immune system makes it possible to 
study the contribution of different immune cell types to disease progression already 
at 1–2 days post fertilization, when functional macrophages and neutrophil develop. 
Furthermore, due to the clear temporal separation of innate immunity from adaptive 
responses, zebrafish larvae are particularly useful for dissecting the innate host factors 
involved in pathology. Recent studies have underscored the remarkable similarity of the 
zebrafish and human immune systems, which is important for biomedical applications 
[41]. Since conserved pathogen associated molecular pattern recognition systems 
are already functional at one day post fertilization, zebrafish embryos and larvae are 
highly suitable for rapid screening of disease progression up to the stage that feeding 
becomes necessary and ethical constraints become apparent [63]. For infection studies 
a common route of infecting zebrafish embryos is the injection of the pathogen into 
the caudal vein of 1 day old embryos [47]. This method is relatively labour-intensive 
and although it has been successfully used for drug screens [64] it compares to cellular 
screening technologies as a low-throughput technique, leading to major bottlenecks in 
25
2
drug discovery. Since infection by immersion in most infection models is not an effective 
alternative [65], we sought to achieve a reliable high-throughput automatic injection 
system, drastically reducing the man hour requirement while vastly increasing the 
number of reproducibly infected embryos. As shown by Carvalho et al. [49] and Veneman 
et al. [39] we have successfully used robotic micro-injection technology for screening 
bacterial proliferation during the first 5 days of larval development. In these studies 
the COPAS technology mentioned above was used to monitor bacterial proliferation. 
Carvalho et al. [49] have also shown that this high-throughput injection method, by its 
versatile applicability in small high safety flow cabinets, can be used for the study of 
infection by dangerous human pathogens such as Mycobacterium tuberculosis owing to 
the fact that this bacterial species can survive within macrophages of zebrafish larvae.
Applications of micro-injection for studies of cancer progression
The zebrafish is increasingly used as a model for the study of cancer progression and 
metastatic potential of tumor cells [16, 66-70]. The optical transparency of zebrafish 
larvae has permitted novel insights into mechanisms underlying tumor cell migration 
and the role of host recognition factors that are highly useful for the study of human 
cancers [71-73]. High-throughput methodologies have been applied in oncologic small 
molecules screens in zebrafish [74-77], however, testing has mainly been performed 
by addition of potential therapeutic drugs to the swimming water of zebrafish as 
micro-injection of drugs has been hampered by technical limitations in the throughput 
level. However, the use of artificial carriers that can be used for slow release of drugs 
has been shown to be highly applicable for future screening for efficacy or toxicity of 
therapeutics in zebrafish [78]. Especially promising for disease studies in general is the 
use of photodegradable biogels that can be used for controlled release of compounds 
[79]. Micro-injection technology has been extensively applied for xenografting of cancer 
cells and non-transformed cells, including stem cells [68, 72, 80-86]. It was shown 
that many cancer cell types from mammalian origin can survive for extended periods 
during larval development and that proliferation and spreading can be monitored using 
automated methods [87]. Clonal zebrafish lines which allow serial transplantations of 
tumor cells from one fish to another without detrimental gamma-irradiation or usage 
of immunosupressants can be used for studying the behaviour of xenografted tumor 
cells in zebrafish after an adaptive immune system has developed [88]. Various studies 
have explored the possibilities for injecting cancer cells in different tissues of zebrafish 
embryos or larvae during different developmental stages. For instance injection of 
mammalian cancer cells into the yolk, cardinal vein, duct of Cuvier, or hindbrain can 
lead to efficient proliferation and spreading, depending on which tumor cell line is used 
[72, 80-83, 85, 87]. It has been indicated that automatic robotic injection of tumor cells 
can also be performed using robotic technology [49]. In this paper we provide methods 
for automated injection of tumor cells in early pre-gastrulation stage zebrafish embryos 





General injection and screening protocol
Robotic micro-injection was performed using needles from the company Qvotek (Table 
1). For comparisons we have used borosilicate glass capillary needles [47], made with 
a Harvard Apparatus needle puller. Although these needles are perfectly suitable for 
manual injection, the commercial needles were needed for robotic injection in order 
to obtain highly reproducible results. For DNA, morpholino and bacterial injections, 
needles with an inner tip diameter of 10 µm were used, whereas for cancer cell injections 
needles with an inner diameter of 20 µm were used. For injection we used a specially 
designed grid that has been described previously by Carvalho et al. [49]. Zebrafish 
embryos were placed on a 1% agarose covered grid with a featured honeycomb pattern 
consisting of 1024 hemi-spherical wells (1.3 mm diameter), except for DNA injection 
where a new grid with 9 blocks of 100 wells was used. The embryo grid was placed 
in a motorized stage coupled to a controller and a motorized micro-manipulator. The 
loaded injection needle was placed in the Injectman II (Eppendorf). The injection height 
was set using a new precise z-calibration unit (Life Science Methods BV), consisting of 
a prism fixed next to a hole in the multi-well plate holder which offers a side-view of 
the needle (Qvotech) when lowered into this hole. For calibration the hole is centered 
above the lens and a needle is lowered into the hole until a dot appears on the screen. 
The user then clicks on the dot to center the needle with a precision of smaller than 
4 pixels (10 µm). Subsequently, the prism is centered above the lens and the needle is 
moved to the focal plane of the prism. On the screen a side view of the needle appears 
and the user clicks on the tip of the needle to calibrate the needle height with equal 
precision. This 3D datum position is then used to calculate the injection point in the 
Parameter Value 
Start capillary Borosilicate 100 mm x 1 mm O.D. (0,75 mm I.D.) 
Tip end Beveled and heat-formed spike 
Tip angle No 
Orientation of tip opening Top 
Flexibility of tip Rigid 
Taper Short 
Inner tip diameter, bacterial injections 10 μm 
Inner tip diameter, tumor cell injections 20 μm 
 




egg with an accuracy of 10 µm in 3D. All components were connected to the controlling 
computer (linutop, www.linutop.com), which was equipped with a software control 
program written in python (Life Science Methods BV). For subsequent high-throughput 
screening we made use of the COPAS XL (Union Biometrica) as described previously 
[39, 49]. For post sorting analysis of the data we have developed a new script, written 
in the software package Perl, which can show the distribution of fluorescence pixels in 
the body of zebrafish larvae as demonstrated with data shown in the bacterial infection 
section (Figures. 1 and 2).
Figure 1: Progression of the bacterial burden in whole embryos (A) or the tail section of the same embryos 
(B). Groups of at least 50 embryos were analysed between 3 dpi to 6 dpi and red fluorescent signal was 
measured and shown in the graphs as mean ± S.E. Different letters indicate statistical significant differences 
between embryos of the same treatment (P < 0.05). ns, no significant differences.
Figure 2: Quantification of fluorescence 
intensity of S. epidermidis injected 
embryos using the COPAS XL and PERL 
macro. The bar graph represents the 
average fluorescence intensity from 
4 biological replica’s (70 embryos per 
group) in the tail and the entire body at 




We injected a DNA construct containing a GFP fusion gene (beta actin promoter-
NLSmCherry-IRES-GFP) in the Gateway Tol2 vector together with Tol2 transposase 
RNA using standard protocols [43] in the middle of the yolk before the first cell-stage. 
This resulted in fluorescence outside of the yolk at 6 days post implantation (dpi) in 
15% of the cases (results not shown). High-throughput injection in combination with 
subsequent COPAS sorting of fluorescent larvae could make up for this low yield. 
However, since it has been reported that DNA-constructs should be injected close 
to or inside the first cell of the embryo proper to improve integration efficiency, an 
alternative semi-automated solution was developed. A new macro was developed to 
move the stage to an egg, show an image of the egg, after which the user determines 
the best injection spot. The pointer is moved to this spot and a mouse-click initiates an 
injection. After the injection the macro moves the robot to the next egg. Injections were 
performed close to the cell and in the first cell, and yield was measured as number of 
embryos showing fluorescence outside the yolk divided by the total number of injected 
embryos at 6 dpi using a Leica MZ16FA stereo fluorescence microscope. To reduce the 
delay between different sets of injections, a new grid was used featuring nine blocks of 
100 wells. Using a scalpel the agarose grid was cut after injections and the blocks were 
harvested separately. The yield of semi-automated DNA injection directed just under 
the first cell is shown in Table 2 demonstrating a yield (at 6 dpi) that is similar to manual 
injection when COPAS sorting is used (Table 2), however the throughput (<5 s per egg) 
as well as simplicity (one mouse click) of semi-automated injection is far greater. The 
semi-automated injections of DNA will be fully automated for future applications by 
recording a database of images together with their best injection spot. Automated 
image recognition can be used to find the best correlating image from this database. As 
such we expect to achieve a speed of 1500 eggs per hour for DNA constructs. In order 













# inj./min Successful 
inj./min 
Manual injection (in the cell) not 
sorted at 1dpi 
63 79 38 25 2.5 1.0 
Manual injection (yolk center) not 
sorted at 1dpi 
120 83 29 15 8.0 2.3 
Full-automated (yolk center) selected 
using COPAS at 1dpi 
524 35 52 15 34.9 5.2 
Semi-automated injection (close to 
the cell) not sorted at 1dpi 
223 25 43 20 11.2 4.1 
Semi-automated injection (close to 
the cell) selected using COPAS at 1dpi 
223 25 79 20 11.2 2.1 
 
Table 2: Comparison of different DNA injection methods. Fully-automated and semi-automated methods 
show 2–3 times higher success rate per minute compared to manual methods (last column). COPAS sorting 
at 1 dpi can almost double (79% vs 43%) the chance of DNA expression at 6 dpi.
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Injection of bacteria and screening for bacterial infection
We previously published the development of an automatic injection system for yolk 
injection in zebrafish embryos [49]. In brief, at 2 h post-fertilization (hpf) or 4 hpf, 
zebrafish embryos were placed in the 1024 wells agarose grid and injected within 
half an hour. The system was successfully applied to M. marinum and M. tuberculosis 
injection in zebrafish embryos, which serve as a promising model for anti-tuberculosis 
drug screening [49]. In addition we have also applied this method for injection of S. 
epidermidis at 2 hpf. The results show that the number of injected bacteria is highly 
reproducible as estimated using plating of bacteria or COPAS analysis. We also have 
shown that COPAS analysis can reliably reproduce counting by bacterial plating thereby 
providing a versatile method for quantification of bacterial proliferation [39]. In addition 
to the capacity of the COPAS technology to sort embryos based on preset fluorescence 
or optical density properties, we show that it can also be useful for quantification of the 
distribution of injected particles using a specially designed Perl script. To demonstrate 
this we have analyzed the data obtained from a M. marinum infection experiment 
in which the injected larvae were analyzed for bacterial spreading in the larva in the 
presence or absence of the antibiotic rifampicin. Zebrafish embryos between 16 and 
64 cell stage were injected with 40 cfu (colony forming units) of M. marinum strain 
E11 expressing the fluorescent protein mCherry. Three days post-injection larvae were 
analysed and presorted using the COPAS XL (Union Biometrica). Presorting settings were 
established in order to ensure a homogenous group of embryos presenting moderate 
infection levels, discarding non-infected and highly infected embryos. Sorted larvae 
were treated with either 0.2% DMSO (control) or 200 µM rifampicin. Embryos were 
treated and infection levels were analyzed with COPAS XL for three days. The resulting 
optical density and red fluorescence profiles were analysed with a custom made script. 
The script reads the optical density and the red fluorescence profiles from a larva. It then 
divides both profiles in two and sums the optical density values and red fluorescence 
values for each half. The anterior half of the larvae is optically more dense compared 
to the posterior half and will have a higher sum. The lower optical density sum will 
determine the posterior half of the profile. The sum of the red fluorescence values for 
this half is the tail fluorescence and the sum of both halves is the total fluorescence. 
This allows us to analyse infection levels either in the whole larvae or in the tail section. 
The results (Figure 1) show that bacteria can be detected with high sensitivity in the 
tail part of the larvae. We have also used this method for reanalysis of the previously 
published data set for S. epidermidis injection that was used for yielding a reference 
transcriptome database [97]. The results (Figure 2) show that injected staphyloccoci 
massively spread into the tail part starting two days after injection providing quantitative 
data that further support the images from confocal laser scanning microscopy [39].
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Injection of bacteria in combination with antisense morpholinos
The conventional procedure of gene function analysis during bacterial infection in 
zebrafish embryos is to inject morpholino oligonucleotides at 1–2 cell stage into 
the yolk followed by bacterial injection into the caudal vein after the onset of blood 
circulation. This method is well-established but time consuming and low-throughput 
[89]. The labour intensity of such injections can be overcome by carrying out co-
injection of morpholino and bacteria into the yolk of 1–2 cell stage zebrafish embryos 
using the automated injection system. This experimental setup was first tested 
using a morpholino oligonucleotide (GeneTools, Oregon, USA) designed against the 
transcription factor Pu-1 (Spi1) that blocks myeloid development [49]. These results 
confirmed the methodology and prompted us to investigate the function of more specific 
immune regulatory factors such as a follow up study on myeloid differentiation factor 
88 (Myd88), an adaptor protein in Toll-like receptor signalling that has been studied by 
gene knock-down and gene knock-out analysis in zebrafish embryos, and shown to be 
involved in proinflammatory innate immune response to microbial infection [89, 90]. 
For this, one nanoliter of MyD88 morpholino at 1.6 mM concentration was co-injected 
with 40 cfu of M. marinum at the 1–2 cell stage into the yolk of zebrafish embryo. 
Analysis of the fluorescence profile of 5 days post-injected embryos using the COPAS 
technology showed an increased bacterial burden in the morphant group compared to 
the control group due to knock-down of this gene (Figure 3). These results mimic the 
already published infection studies with Myd88 knock-down, confirming that automatic 
yolk co-injection of morpholino and bacteria is capable of creating reproducible results 
for morpholino screens in a high-throughput manner.
Figure 3: Automatic co-injection of antisense 
morpholino and bacteria into yolk. Increased bacterial 
burden was measured using the COPAS system in 
MyD88 and control morphants at 5 dpi following co-
injection of M. marinum with MyD88 morpholino into 
1–2 cell stage zebrafish embryos. Significant difference 
was tested by unpaired t-test.
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Tumor cell implantation and screening for proliferation and spreading of cancer cells
1. Robotic injection of tumor cells
In manual injection experiments various tumor cell lines were shown to be highly 
different in their capacity to proliferate and spread into the entire zebrafish body after 
injection into the yolk of pre-gastrulation stage embryos. Pilot experiments using the 
injection robot with the highly aggressive osteosarcoma cell lines SJSA-1 (American 
Type Culture Collection, ATCC) and osteosarcoma line L2792 [91] showed a massive 
proliferation and strong spreading of fluorescent cells in the tail at 3 days post injection 
into the yolk at the 256 cell stage (Figure 4). For further implantation assays shown in 
this paper, human prostate cells (PC3 and LNCap) and a highly angiogenic melanoma 
line (Mel57-VEGF) were used. The latter line was chosen because a stably transfected 
line was available that yielded a bright fluorescent signal that could be measured 
reproducibly at low cell counts using the COPAS technology.
Figure 4: Confocal laser scanning analysis of 5 
days old larvae injected with osteosarcoma 
cell line SJSA-1 at the 256 cell stage. For these 
studies a transgenic zebrafish Tg(Fms:Gal4, 
UAS:mCherry) was used [100]. The figure shows 
a z-series projection of a part of the tail area 
with the mCherry signal shown in orange and 
in red the proliferation and strong spreading 
of the CM-DiI labelled cancer cells. Blue color 
represents autofluorescence
In order to investigate the dissemination of tumor cells in zebrafish embryos, we 
developed an optimal setup for the establishment of a high-throughput xenograft model 
using the automated injection system. Cells were cultured as previously described i.e. 
in RPMI-1640 medium (Sigma Aldrich) supplemented with fetal bovine serum to a final 
concentration of 10%. Cells were subdivided 2–3 times a week at ratio of 1:5–1:10. 
Cultures were renewed every 8 passages. During subdividing care was taken that single 
cells were passed so no aggregates have formed. For transplantation, cells with 75–80% 
confluency should be used as they tend to clump less then more confluent cell cultures. 
For detection of cancer cells we mostly have used CM-DiI labeled cell cultures that 
were labeled using the following protocol: T75 flask with cells reaching 80% confluency 
were gently but quickly rinsed with 1 ml Trypsin–EDTA. For getting cells into suspension, 
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cells were covered with 0.5 ml of Trypsin–EDTA and incubated for 2–5 min at 37 ˚C. 
Trypsination was stopped by adding 1 ml of PBS with 10% FCS and cell lumps were 
broken by gentle pipetting up and down. From this step no visible cell aggregates 
should be observed. Single cells were pelleted by centrifugation at 100g for 4 min in a 
2 ml Eppendorf tube. Pellets were resuspended in 0.5 ml PBS with CM-DiI (InVitrogen) 
incubated first at 37 ˚C for 5 min and later at 4 ˚C for an additional quarter of an hour. 
After this step, cells were centrifuged again at 100g for 4 min, washed once in 0.5 ml 
PBS and counted. Finally cells were resuspended in 14% PVP to a final concentration 
of minimum 200 cells per microliter. Prior to injection, the labelled cells were kept at 
34 ˚C and implanted within 3 h. Transgenic cells were treated in a similar way but the 
step related to incubation with a dye was omitted. As a control, fish were injected with 
14% PVP. Due to the size of tumor cells, the suspension was loaded into glass capillary 
needles with bigger opening (Qvotech, 20 micron, Table 1). Up to 5 nl volume with 
minimum 400 cells were implanted using the robotic injector. Successfully injected 
embryos (around 80–90% rate) were either sorted manually under a fluorescence 
stereoscope (Leica) or sorted by the COPAS XL. Zebrafish embryos were maintained in 
groups of 50 in a Petridish with 20–25 ml egg water and kept at 34 ˚C until 6 dpi. Using 
a Tg(fli:GFP) endothelial reporter transgenic zebrafish line with fluorescent vasculature 
[92], we found that PC3 and LNCap cells transplanted robotically behaved in the same 
way as manually transplanted cells [87]. The first clearly disseminated fluorescent 
tumor cells were observed at 5 dpi in the caudal vein, and also in other small vascular 
in the eye and intersegmental vessels (Figure 5). These experiments showed several 
important technical aspects of the micro-injection procedure. High concentration of 
PVP prevented cell clumping and needle clogging. However, as highly concentrated PVP 
is very viscous, it is difficult to work with. For cells that are kept in suspensions, lower 
concentration of PVP will be sufficient (e.g. 2%). It is also important to note that cell 
dissemination has only been observed when the number of implanted cells reached 
at least 400. When lower numbers of cells were implanted into an early embryo, even 
highly aggressive cells did not migrate out of the yolk. 
Figure 5: Automatic injection of tumor cells into 
zebrafish embryos resulted in tumor dissemination. (A 
& B) Confocal z-series projection and (C & D) bright-field 
of fluorescent cell tracker CM-DiI labeled LNCap cells 
disseminated to the tail vascular of a 7 day-old larva. 
Images were acquired using a Leica TCS SPE confocal 
microscope with an x20 dry objective.
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2. Confocal screening and tumor cell dissemination
Taking advantage of the transparency of zebrafish larvae, we performed high-resolution 
confocal microscopy laser scanning imaging to characterize the dissemination of 
injected tumor cells in the case of the PC3 and LNCAP cell lines (500 cells injection). 
It is known that leukocytes contribute to different steps of tumor progression [72, 93, 
94]. In order to investigate the role of embryonic myeloid cells in cancer cell spreading 
or killing of cancer cells, whole-mount L-plastin immunohistochemistry was carried out 
as described [95]. Antibodies and dilutions were used as follows: L-plastin rabbit anti-
zebrafish primary antibody (provided by Dr. Huttenlocher), was diluted 1:500 and the 
secondary antibody (Alexa 568 anti-rabbit, Invitrogen) was used at a 1:200 dilution. 
At 6 dpi, confocal imaging of fixed larvae revealed the presence of labeled cells in the 
vascular system, indicating that injected human tumor cells survived and disseminated 
outside the yolk (Figure 6). Noteworthy, we also detected that labeled tumor cells were 
accompanied by a leukocyte population at various positions in the tissue (Figure 6), 
suggesting that myeloid cells have a role in cancer cell recognition. In future studies we 
will study whether differences in dissemination are correlated with the aggressiveness 
of tumor cell type. For this we will use a combination of the automated injection system 
together with published high-throughput imaging technologies [87] to screen for the 
malignancy of many different mammalian cancer cell lines in the zebrafish embryo 
model at higher throughput levels than previously established.
Figure 6: Confocal screening of tumor 
cell dissemination in zebrafish embryos. 
PC3 and LNCap (red color) injected in 
embryos showed clear dissemination 
from the original implantation site at 6 
dpi. Leukocytes (in blue) associated with 
tumor cells are visible at the dissemination 
site with the vascular system in green (this 
signal is omitted in the in bottom panels). 
Two representative images are shown of 
embryonic leukocytes associated with 
fluorescent tumor cells at the caudal vein. 
Images were acquired using a Leica TCS 




3. COPAS screening for tumor cell proliferation
To demonstrate the survival rate and proliferation of injected tumor cells in zebrafish 
embryos, we employed a stably transfected melanoma cell line Mel57-VEGF expressing 
EGFP, [96] in our robotic injection system. A large set of embryos were injected with Mel57-
EGFP cells (400 cell/embryo) at 2 and 4 hpf. The injected embryos were immediately 
run through the COPAS system to determine the total level of green fluorescence, 
which represents the injection load. The embryos were subsequently sorted with the 
following parameters: optical density threshold (extinction) = 390 mV (COPAS value: 
20), minimum time of flight = 280 ms (COPAS value: 700), red photomultiplier tube 
(PMT) voltage = 0 V, green PMT voltage = 600 V, yellow PMT voltage = 0 V, fluorescent 
density threshold = 800. Successfully injected embryos were followed with the COPAS 
system until 6 dpi. 
Combination of COPAS profiling and epifluorescence/brightfield imaging revealed 
significant tumor cell proliferation in the injected embryos (Figure 7). At the first day 
after injection, the fluorescent signal of tumor clusters slightly dropped, suggesting a 
decrease of live cells due to the implantation process. At 6 dpi, the average signal per 
larva had significantly increased, and was almost 2-fold higher than at 1 dpi (Figure 7). 
These results illustrated the ability of COPAS to accurately quantify the number of tumor 
cells in zebrafish embryos. This shows that the combination of the automatic injection 
and COPAS sorting system provides a powerful in vivo platform for the investigation of 
human cancer proliferation, which in turn highly facilitates the discovery and screening 
of anti-cancer compounds directed at targets from the implanted cells and the recipient 
host. Based on these results we have recently started with follow up studies using 
our methods of xenografting with many other cancer cell lines aimed at obtaining 
mechanistic insights in the spreading of cancer cells through the zebrafish body. These 
studies already have indicated that using this methodology new knowledge can be 
obtained in proliferation and metastatic behaviour of Ewing sarcoma cells (manuscript 
in preparation). This is of clinical relevance since at the time of diagnosis “”25% of 
Figure 7: Proliferation of automatic injected Mel57 
cells in zebrafish embryos. Total fluorescent signal 
intensity quantifies the increase of tumor cell number 
in the injected embryos over 6 days. The sample size 
for each experiment was >400 embryos. More than 
150 successfully injected embryos were sorted out at 
1 dpi. Final survival rate was >80% at 6 dpi.
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Ewing sarcoma patients, predominantly children and young adults, present with 
metastatic disease and a poor survival prognosis. In case of recurrence of the disease, 
overall survival rates are as low as ‘’10–20%’’. Although the causative underlying defect 
is known, there are currently no reliable treatment strategies for this malignant bone 
tumor. Therefore, high-throughput screening is greatly needed for rapid preclinical drug 
screens for this type of tumor.
Conclusions
The provided methods for robotic micro-injection of DNA, morpholinos, bacteria and 
cancer cells in zebrafish embryos enables the generation of an abundance of reproducibly 
treated living test models. In Table 3 we present a summary of variables that we have 
tested with our developed technology. We have shown that this technology benefits 
optimally from many new high-throughput screening methods. These methods are 
not only applicable to the disease models highlighted in this paper, i.e. cancer and 
infectious disease, but are widely applicable to studies that benefit from the use of 
small transparent zebrafish larvae. We anticipate that our technology is also applicable 
to other fish models. For instance the use of carp fish, which are easy to culture and have 
a clutch size of hundred thousands of eggs in one spawn, would be extremely useful 
for screens in larvae at ultra high-throughput level [6]. We have recently generated a 
draft genome of the European common carp (Cyprinus carpio) showing a striking gene 
similarity with the zebrafish, but, a much higher compactness of the genome, making 
it highly interesting for further comparative studies with zebrafish at the genetic level 
[97]. In our own research we will continue to use zebrafish and other fish species for 
applications in disease studies, but, we will also give more attention to the applicability 




Variables tested Limiting factors 
DNA • Position of injection 
• COPAS screening 
• Higher accuracy of injection site will limit speed 
Morpholinos • Combination with microbial 
injection 
• Morpholinos have to be injected as early as possible 
Microbes • Different types of microbes (e.g. 
Mycobacteria and Staphylococci) 
• Embryonic stage of injection 
• Microbial escape from yolk 
• There is a delay period before bacteria from yolk will be exposed to 
cellular immune responses (e.g. phagocytosis) 
• For whole organism screening there will be background fluorescence 
from microbes in the yolk 
Cancer cells • Cancer cell types 
• PVP concentration 
• Spread to different body parts 
• Embryo survival rates 
• Clumping of cells that will clog needles 
 
Table 3: Overview of robotic injection applications. For details on the microbial robotic injection variables 
tested we also refer to Carvalho et al., 2011 [49] and Veneman et al., 2013 [39].
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that the combination of screens for potential new therapeutics will benefit greatly in 
speed by a combination with toxicology approaches. In the near future the use of our 
micro-injection technology will also be used for detailed drug RP/KD studies that should 
give indications on the translatability of drug treatment effects and might suggest 
protocols for optimized drug administration. For this the injection of synthetic slow or 
controlled release vehicles in combination with highly sensitive detection of compounds 
using mass spectrometry will be highly valuable [38, 78, 79, 99].
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Zebrafish are becoming a valuable tool in the preclinical phase of drug discovery 
screenings as a whole animal model with high-throughput screening possibilities. They 
can be used to bridge the gap between cell based assays at earlier stages and in vivo 
validation in mammalian models, reducing, in this way, the number of compounds 
passing through to testing on the much more expensive rodent models. In this light, in 
the present manuscript is described a new high-throughput pipeline using zebrafish as 
in vivo model system for the study of Staphylococcus epidermidis and Mycobacterium 
marinum infection. This setup allows the generation and analysis of large number of 
synchronous embryos homogenously infected. Moreover the flexibility of the pipeline 
allows the user to easily implement other platforms to improve the resolution of the 
analysis when needed. The combination of the zebrafish together with innovative 
high-throughput technologies opens the field of drug testing and discovery to new 
possibilities not only because of the strength of using a whole animal model but also 
because of the large number of transgenic lines available that can be used to decipher 
the mode of action of new compounds.
Introduction
To date the zebrafish (Danio rerio) has been successfully established as an efficient 
model to study a variety of infectious diseases [1]. The zebrafish embryo offers unique 
in vivo imaging possibilities due to their transparency and the large number of existing 
transgenic reporter lines expressing fluorescent proteins. This powerful combination 
makes it possible to track different immune cell types in time while interacting with 
pathogens such as Mycobacterium marinum, the closest relative of M. tuberculosis [2], 
or Staphylococcus epidermidis, the main causative of biomaterial-associated infection 
[3-5]. Different routes of infection can be used in zebrafish embryos depending on the 
purposes of the study [6]. 
One of these infection routes is yolk injection of the bacteria. The main advantage of this 
method compared to the others is that yolk infection can be performed automatically 
via robotic injection, significantly reducing the injection time and allowing high 
reproducibility of the infection [7, 8]. 
Previous work, using the zebrafish as a high-throughput in vivo model system for the study 
of S. epidermidis and M. marinum infection showed to be successful [7, 8]. This system 
is able to screen for disease progression via robotic yolk injection of early embryos and 
using fluorescence readout as a measure for the bacterial load. In agreement with this 
notion, this setup has been optimized and established a highly efficient high-throughput 
pipeline with the potential to generate large numbers of homogenously infected 
embryos and track the progression of the infection during the time after treatment 
with a number of compounds. With the established setup it is possible to generate up 
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to 8000 synchronous embryos to screen for disease progression, processing in this way 
up to 2500 embryos per hour. Embryos are sorted based on their bacterial load using 
an automated system, ensuring homogenous groups of infected larvae. Furthermore, 
to validate the setup, effects of reference known to prevent tuberculosis progression 
in mammals have been tested on embryos infected with M. marinum E11 strain or the 
more virulent M strain [9]. 
This study describes in detail the high-throughput pipeline that has been established to 
be able to generate large numbers of infected embryos and the subsequent analysis of 
the bacterial progression during development and after compound treatment.
Protocol
1) Bacterial strains and growth conditions
1.1) Prepare S. epidermidis inoculum
1.1.1) Take several individual colonies from S. epidermidis strain O-47, containing a 
pWVW189 derived mCherry expression vector (De Boer L. unpublished) from a Luria 
Bertani (LB) agar plate supplemented with 10 μg/ml chloramphenicol and culture 
overnight at 37°C in 25 ml LB medium supplemented with 10 μg/ml chloramphenicol 
to mid-log stage.
1.1.2) Centrifuge 1 ml of the culture at 12000 × g for 1 min and subsequently wash them 
3 times with 1 ml sterile phosphate-buffered saline (PBS) with 0.3% V/V Tween80.
1.1.3) Measure the optical density at 600 nm (OD600), and dilute the bacterial suspension 
to an OD600 of 0.3 in 2% W/V polyvinylpyrrolidone40 (pvp40) in PBS. Note: an OD600 of 0.3 
corresponds to 1.0×108 colony forming unit/ml (cfu/ml).
1.2) Prepare M. marinum inoculum
1.2.1) Take several individual colonies from M. marinum strain M or E11 containing 
the pSMT3-mCherry vector stably expressing mCherry [10] from a Middlebrook 7H10 
agar plate with 10% V/V Middlebrook OADC enrichment supplemented with 50 μg/ml 
hygromycin and culture overnight at 28°C in 10 ml of Middlebrook 7H9 broth with 10% 
V/V Middlebrook ADC enrichment supplemented with 50 μg/ml hygromycin.
1.2.2) Centrifuge 1 ml of the culture at 12000 × g for 1 min and subsequently wash it 3 
times with 1 ml sterile PBS with 0.3% V/V Tween80.
1.2.3) Measure the OD600, and dilute the bacterial suspension to an OD600 of 0.3 in 2% 




2) Prepare zebrafish eggs
2.1) Place maximum 70 male and 50 female wild type zebrafish separately into the large 
breeding vessel. Note: place the female fish in the lower part of the large breeding 
vessel.
2.2) Remove the separator the next day in the morning, to let the zebrafish start 
breeding.
2.3) Collect the eggs at the bottom of the large breeding vessel through the egg collector 
in a 50 ml tube filled with egg water (60 µg/ml Instant ocean sea salt).
3) Injection needles
3.1) Obtain commercially available custom made glass capillaries needles with an inner 
diameter of 10 µm.
4) Experimental outline of injection
4.1) Boil 100 ml of 1% W/V agarose in egg water, and cool until approximately 40˚C. 
Pour agarose into the automated micro-injectors plate and place the 1024 well stamp 
into the agarose. Note: the plate is ready to use when cooled down.
4.2) On the automated micro-injector operating software click on ‘Calibrate stage’, then 
click on ‘1024’ well grid and place the agarose plate in the micro-injector and calibrate 
the plate by clicking on the screen at the centre position of the well. 
4.3) Go to ‘needle menu’ and click on ‘calibrate needle holder’.
4.4) Fill the injection needle using a microloader tip with either 10 µl pvp40 containing 
100 cfu/nl S. epidermidis or 30 cfu/nl M. marinum, or use pvp40 as mock injection.
4.5) Place the needle in the automated micro-injector and calibrate the x, y position 
by lowering or moving the needle up and clicking on the screen at the position of the 
needle. Then calibrate the z position of the needle by clicking on the screen at the 
position of the tip of the needle.
4.6) Distribute the eggs over the agarose grid using a plastic transfer pipet, and remove 
excess egg water. Place the agarose grid in the automated micro-injector.
4.7) Go to the ‘Injection menu’ and adjust the ‘Injection pressure’ setting to 200 hPa, 
‘Injection time’ 0.2 s and ‘Compensation pressure’ 15 hPa, which correlates with 1 nl, at 
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the Femtojet settings menu.
4.8) Click on ‘Inject all’ to inject the entire plate.
4.9) Collect the eggs after injection by washing them into a Petri dish (92 × 16 mm), with 
a maximum of 70 embryos per Petri dish, and incubate at 28°C.
5) Flow-cytometer analysis 
5.1) Prepare the large particle flow cytometer according to the manufacturer’s 
instructions and fill the sample cup and sheath fluid container with egg water.
5.2) At the operating software, go to the ‘PMT’ menu and use the following settings: 
650 V for the ‘Red’ channel and 0V for the ‘Green’ and ‘Yellow’ channel. Then go to 
‘Thresholds’ menu and use the following settings: ‘Optical density’ threshold signal: 
975mV (COPAS XL value: 50) and the ‘Time Of Flight’ (TOF) minimum to 320 μs (COPAS 
XL value: 800) in order to reduce the influence of debris. 
5.3 For analysis without sorting the embryos go to step 5.4, for analysis and sorting the 
embryos into a Petri dish go to step 5.5 or for analysis and sorting the embryos into a 
96 well plate go to step 5.6.
5.4) Place the embryos in the sample cup and click on ‘start’ to start the analysis. When 
all embryos are analyzed stop the analysis by clicking on ‘stop’. Save the data by clicking 
on ‘Store’. Note: all data is stored as TXT, LMD, DAT, CSV and BSRT files. Follow the 
protocol at step 5.7.
5.5) Place the embryos in the sample cup and define the maximum of 70 embryos per 
plate to be sorted by entering 70 in the ‘Sort’ menu. Place an empty Petri dish under 
the sorter and click on ‘Manual Sort. When the Petri dish is filled, save the data by 
clicking on ‘Store’. Note: all data is stored as TXT, LMD, DAT, CSV and BSRT files. Follow 
the protocol at step 5.7.
5.6) Place the embryos in the sample cup and define the maximum of 1 embryo per well 
to be sorted by entering 1 in the ‘Sort’ menu. Place an empty 96 well plate into the left 
plate holder and click on ‘Fill plate’. When the 96 well plate is filled, save the data by 
clicking on ‘Store’. Note: all data is stored as TXT, LMD, DAT, CSV and BSRT files. Follow 
the protocol at step 5.7.
5.7) Get the TXT file to process the raw data, use the following data filter settings: 
‘Status select’: 40, and if using the sort module ‘Status sort’: 6. Then use the numbers 
from the total fluorescence signal from the ‘Red’ channel to calculate the average and 




6.1) Analyze and sort at 3 days post injection (dpi), M. marinum infected embryos in 
two equal groups using the large particle flow cytometer (step 5.5). Treat one group 
with a compound of interest in its carrier solvent and other with carrier solvent alone 
(control). Apply similar treatments to mock-injected control to test for antibiotic side 
effects.
6.2) Repeat at 4 and 5 dpi the analysis (step 5.5) and refresh the egg water or egg water 
containing the compound.
7) High-resolution imaging 
7.1) Anesthetize the embryos with 0.02% W/V buffered 3-aminobenzoic acid ethyl ester 
(Tricaine) in egg water 10 min before analysis.
7.2) Prepare the Vertebrate Automated Screening Technology system and the Large 
Particle Sampler according to the manufacturer’s instructions.
7.3) Select the reference images corresponding to the age of the embryos from the 
‘Imaging – Object – Detection Setup’ menu.
7.4) Select the amount of pictures and orientation to be made by the Vertebrate 
Automated Screening Technology system from the ‘Imaging – Auto store images’ menu.
7.5) Place a 96 well plate filled with embryos (from step 5.6) into the left plate holder of 
the Large Particle Sampler, and click on ‘Run plate’.
7.6) When an embryo is detected and correctly positioned; image the head and the 
tail separately with the CLSM using a 10X plain dry objective and stitch the images 
afterwards using image processing software. 
Representative results
The present results show that the high-throughput pipeline to study S. epidermidis and 
M. marinum infection has been successfully established and that may be extended to 
other infection models. Firstly, the use of the large breeding vessel (Figure 1A), based 
on the published system by Adatto et al. 2011 [11], enables to generate large numbers 
of synchronous eggs in single events affording a high control of the spawning process. 
Next to be able to inject large number of embryos in a short period of time, an improved 
version of the previously developed automated micro-injection system [7] was used 
(Figure 1A). To asses which is the best developmental stage for yolk infection, injections 
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with S. epidermidis and M. marinum were performed at all the different stages between 
1 and 512 cell stage, according to the description made by Kimmel et al. 1995 [12].  
Injections with 100 cfu S. epidermidis between the 16 and 128 cell stage provided the 
best infection pattern (Figure 2). The bacteria proliferated inside the yolk for 3 days 
and spread into the body from 3 dpi onwards. Performing injections before the 16 cell 
stage led to high mortality from 4 dpi, and injection after the 256 cell stage showed 
mainly bacterial growth inside the yolk with hardly any bacteria spreading inside the 
body of the embryo. Quantification of bacterial burden was performed by fluorescence 
intensity analysis using the large particle flow cytometer as described by Veneman et al. 
2013 [8] (Figure 3). 
Figure 1: Mainstream experimental outline. (A) Adult fish are put together to mate, eggs are collected, 
aligned into an agarose plate and injected. (B) The injected eggs are incubated at 28°C and will be pre-
sorted for possible drug treatment. (C) Subsequent analysis by large particle flow cytometer and/or Large 
Particle Sampler/Vertebrate Automated Screening Technology with CLSM. 
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Figure 2: Establishment of best cell stage for S. epidermidis yolk injection. Zebrafish embryos were 
injected in the yolk at different developmental stages from 1 to 512 cell stage with 100 cfu of S. epidermidis. 
Embryos injected between 1 and 8 cell stage showed bacterial growth in the yolk and high mortality from 
4 dpi. Embryos injected between 16 and 128 cell stage showed bacterial growth in the yolk and inside the 
body starting at 3 dpi. Embryos injected between 256 and 512 cell stage showed many bacterial growth 
inside the yolk.
Figure 3: Quantification of bacterial burden using large particle flow cytometer. 100 cfu of S. epidermidis 
were injected into the yolk of zebrafish embryos. (A) Up to 5 dpi, each day, groups of 10 embryos were 
homogenized and plated directly, showing the average exponential growth based on two biological replicas 
(error bars = SEM). (B) Large particle flow cytometer analysis shows the average fluorescence signal from 
non-injected and S. epidermidis injected embryos. 30-160 embryos per condition were analyzed (error 
bars = SEM), different letters indicate statistical significant differences by one-way ANOVA followed by 
Tukey's post-hoc test (P < 0.001), ns: not significant differences. (C) Correlation between cfu and average 
fluorescence signal of groups of 10 S. epidermidis infected embryos (error bars = SEM). This figure has been 
modified from Veneman et al. 2013 [8].
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Observations showed that the optimal developmental stage for injection of 30 cfu M. 
marinum injection is between 16 to 128 cell stage for the E11 strain (Figure 4A) and 
between 16-64 cell stage with the more virulent M strain (Figure 4B). Embryos injected 
at these stages showed bacterial growth inside the yolk and spreading of the bacteria 
through the embryo (Figure 7). Infection with both strains at earlier stages presented 
non-specific generalized bacterial growth leading the embryos to die after 4 dpi. On the 
other hand, in embryos injected at later stages bacterial burden was restricted to the 
yolk.
Figure 4: Establishment of the best cell stage for M. marinum yolk injection. Zebrafish embryos were 
injected at all the different developmental stages from 1 to 512 cell stage with 30 cfu of M. marinum 
E11 and M strain. (A & B) Embryos injected from 1-8 cell stage showed similar spreading and mortality 
with both strains. (A) Embryos injected between 16-128 cell stage with E11 strain showed formation of 
granulomas and systemic infection while those injected from 256 to 512 cell stage kept bacterial burden 
into the yolk. (B) Embryos injected between 16-64 cell stage with M strain showed formation of granuloma 




Next, pre-sorting with large particle flow cytometer (Figure 1B) generated large 
homogenous groups of infected fish excluding non- or highly infected embryos 
(Figure 5A and 6A). After pre-sorting, M. marinum infected embryos were treated 
with Rifampicin, a first-line anti-tuberculosis drug. Previous studies demonstrated 
that treatment with Rifampicin at a dose of 200 μM efficiently reduces M. marinum 
infection in zebrafish [7, 13]. Taking advantage of the large number of homogenously 
infected embryos generated with the high-throughput setup, treatment with different 
doses was performed. Embryos infected with M. marinum M strain and treated for 48 
hours with 12, 24 and 200 μM Rifampicin showed to reduce efficiently mycobacterial 
infection in a dose dependent manner (Figure 5B). In view of the efficient reduction 
of the infection using Rifampicin at a dose of 200 μM this concentration was used for 
the future experiments. In line with the previous result, studying bacterial burden 
progression using M. marinum E11 strain a significant reduction 24 hours and onwards 
after treatment with 200 μM Rifampicin was observed (Figure 6B).
Figure 5: Treatment of M. marinum acute infection with a first-line anti-tuberculosis drug. Embryos 
injected between 16-64 cell stage with 30 cfu of M. marinum M strain were run through the large particle 
flow cytometer at 3 dpi to be sorted in two groups after discarding the non- and/or highly infected embryos. 
(A) Fluorescence of individual embryos in both groups. (B) Embryos treated with Rifampicin (RIF) for 48 
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hours at doses of 12, 24 and 200 μM were analyzed at 4 dpi; their bacterial load is significantly reduced. 
(C) Representative COPAS profiles of embryos treated with DMSO and Rifampicin at doses of 12, 24 and 
200 μM for 24 hours. Bacterial load and distribution is indicated by the red peaks. Blue line represents the 
profile of the element sorted (4 dpf zebrafish embryo) by the COPAS. 60-90 embryos per condition were 
analyzed. Each data point represents an individual embryo. Values are indicated as mean ± SEM. ns: not 
significant differences. Analysis of statistical significance of differences was performed by one-way ANOVA 
followed by Tukey's post-hoc test. 
Furthermore, if high magnification imaging is required of these embryos, they can 
be displayed automatically in 96 well plates (Figure 1C), from where the samples can 
be analyzed using the Vertebrate Automated Screening Technology system with the 
Large Particle Sampler mounted onto a CLSM. The Vertebrate Automated Screening 
Technology system with the Large Particle Sampler is a system that can either be 
mounted onto a CLSM or stereo microscope. This device allows the loading of live or 
fixed embryos from a 96 well plate or bulk container automatically through a glass 
capillary, and orientates it in front of the camera at the desired angle (e.g. dorsal or 
lateral). Images of the embryo in all orientations can be made with the on board camera 
or with an external CLSM (Figure 7). Embryos will subsequently be transferred in the 
collection or waste container.
Figure 6: Treatment of M. marinum chronic infection with a first-line anti-tuberculosis drug. Embryos 
injected between 16-64 cell stage with 30 cfu of M. marinum E11 strain were run through the large particle 
flow cytometer at 3 dpi to be sorted in two groups after discarding the non- and/or highly infected embryos. 
(A) Fluorescence of individual embryos in both groups. (B) Embryos treated with Rifampicin (RIF) at 200 μM 
during 4 days were analyzed showing a significant reduction of the bacterial load after 1 day of treatment. 
90 embryos per condition were analyzed. Values are indicated as mean ± SEM. Different letters indicate 
significant differences between time points of the same treatment. * indicates significant differences 
with control group. ns: not significant differences. Analysis of statistical significance of differences was 
performed by one-way ANOVA followed by Tukey's post-hoc test. (P < 0.05). Figure B) has been modified 




The high-throughput methodology described in this paper provides a fast and cost 
effective pipeline to screen high number of fish embryos and larvae with different 
types of infections. Using the large breeding vessel instead of traditional single or 
family breeding tanks facilitated control of the spawning process and generation of 
larger number of synchronous eggs. With an improved version of the automated micro-
injection system [7], it is possible to inject up to 2500 eggs almost all in the same cell 
stage within 1 hour. With these updates and improved software it is feasible to inject 
more eggs than previously was possible which can be used to perform large drug screens 
with bacterial proliferation as a read out. However this method is still limited to yolk 
injection, other injection routes for example described by Benard et al. 2012. [6], will 
hopefully be incorporated in the automated micro-injection system in the near future.
Although these methods are benchmarked for screening zebrafish, it would be useful 
for applications with other fish species as well. For instance, the common carp has 
been indicated to have advantages for drug screens. Like zebrafish, eggs and early stage 
embryos from common carp are transparent but with the main advantage of its large 
spawn size of hundred thousands of eggs and the availability of inbred lines that offer a 
more constant genetic background [14]. 
Figure 7: Result of M. marinum E11 yolk injection imaged using Vertebrate Automated Screening 
Technology and CLSM. Confocal Z stack (stitched 3 images) of a 5 dpi Tg(fli1-egfp) [17] embryo. (A) Live 
embryo showing proliferation of M. marinum E11 bacteria (red) throughout the body. (B) Fixed 5 dpi Tg(fli-
egfp) embryo showing M. marinum E11 bacteria (red) throughout the body co-localizing with leucocytes 
(light blue) detected by L-plastin immunostaining [18].
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The analysis of large amounts of infected embryos is done with the high-throughput 
large particle flow cytometer. This device can sort analyzed embryos into multi 
well plates or a Petri dish making it especially suitable for testing large numbers of 
compounds. If a higher imaging resolution is needed, than the setup is adapted in a way 
that the large particle flow cytometer technology can be used for pre-screening and 
subsequently analyze the samples at a medium throughput at a higher resolution. This 
can be done using the Vertebrate Automated Screening Technology [15, 16]. This device 
can automatically collect live or fixed embryos between 2 and 7 days post fertilization 
from a multi well plate or bulk container, image 360° through a capillary using CLSM or 
stereo microscopy and dispose again in 2 bulk containers allowing manual sorting of the 
embryos based on the microscopic images. Future improvements will allow the sorting 
of the embryo after imaging into the multi well plate, therefore making it possible 
to screen automatically large number of individual embryos over time with CLSM. 
Assuming that in future applications the Vertebrate Automated Screening Technology 
system can also be connected to the large particle flow cytometer technology without 
the need of prior dispensing larvae into multi well plates, will lead to a more advanced 
sorting.
This paper describes the establishment and optimization of a high-throughput setup 
to study S. epidermidis and M. marinum infection as a model for drug discovery. It 
demonstrates that the outcome of these bacteria injected into the yolk depends on the 
developmental stage of the eggs at the time of injection. Injecting M. marinum E11 at 
16-128 cell stage or the M strain at 16-64 cell stage leads to the same infection pattern 
as caudal vein injection [2, 6]. However this setup is not limited to the proliferation of 
bacterial pathogens only. It was shown before that it is possible to robotically inject 
solutions containing DNA, RNA or morpholinos for transgenesis, over-expression and 
gene knock-down studies, respectively [13]. Furthermore, it was shown that this setup 
is also useful for the study of cancer cell proliferation and migration. Therefore this 
pipeline presents a versatile method for high-throughput screens of a variety of signal 
mechanisms in the context of innate immunity, applied to infectious disease and the 
development of cancer. These screens can be combined with others for medicine 
discovery but also with analysis of possible toxic effects of identified applicable drugs.
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Staphylococcus epidermidis bacteria are a major cause of biomaterial-associated 
infections in modern medicine. Yet there is little known about the host responses against 
this normally innocent bacterium in the context of infection of biomaterials. In order 
to better understand the factors involved in this process, a whole animal model with 
high-throughput screening possibilities and markers for studying the host response to 
S. epidermidis infection are required. 
We have used a zebrafish yolk injection system to study bacterial proliferation and the 
host response in a time course experiment of S. epidermidis infection. By combining 
an automated micro-injection system with Complex Object Parametric Analysis and 
Sorting (COPAS) technology we have quantified bacterial proliferation. This system was 
used together with transcriptome analysis at several time points during the infection 
period. We show that bacterial colony forming unit (cfu) counting can be replaced 
by high-throughput flow-based fluorescence analysis of embryos enabling high-
throughput readout. Comparison of the host transcriptome response to S. epidermidis 
and Mycobacterium marinum infection in the same system showed that M. marinum 
has a far stronger effect on host gene regulation than S. epidermidis. However, multiple 
genes responded differently to S. epidermidis infection than to M. marinum, including a 
cell adhesion gene linked to specific infection by staphylococci in mammals.
Our zebrafish embryo infection model allowed (i) quantitative assessment of bacterial 
proliferation, (ii) identification of zebrafish genes serving as markers for infection with 
the opportunistic pathogen S. epidermidis, and (iii) comparison of the transcriptome 
response of infection with S. epidermidis and with the pathogen M. marinum. As a 
result we have identified markers that can be used to distinguish common and specific 
responses to S. epidermidis. These markers enable the future integration of our high-
throughput screening technology with functional analyses of immune response genes 
and immune modulating factors.
Introduction
Infections with Staphylococcus epidermidis bacteria pose a serious problem associated 
with the use of biomaterials in modern medicine [1-5]. These bacteria can form biofilms 
on the surface of inserted biomaterials and persist in the surrounding tissues, where 
immune functions are disturbed due to the combined presence of a biomaterial and 
the bacteria [6, 7]. In order to better understand the cause of this phenomenon and 
to assess the propensity of different bacterial strains and biomaterials to alter and 
trigger the immune response in the host, a whole animal model with high-throughput 
screening possibilities is desired. This will help identifying which factors determine that 
innocent bacteria become less susceptible to host defence mechanisms or antibiotic 
treatments when associated with biomaterials. Mouse and rat models have been used 
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to investigate S. epidermidis infection and biomaterial-associated infection processes. 
However, histological examination of biopsies is time consuming and does not allow 
following the infection process over time [8-10]. Even with the use of bioluminescence 
and fluorescence imaging, high challenge doses are required to visualize bacterial 
colonization and high-throughput screening in rodents is not feasible. However, the 
zebrafish at the embryonal and larval stages is an excellent model for this purpose: it 
is translucent, fluorescently labelled immune cells and bacteria can be microscopically 
imaged in real time, and embryos can be obtained in high numbers [11-15]. The 
responses of many different pathogens such as Escherichia coli, Mycobacterium 
marinum, Salmonella typhimurium, Edwardsiella tarda, Burkholderia cenocepacia, and 
Staphylococcus aureus have already been assessed in zebrafish [16-21]. In previous 
work we successfully performed extensive transcriptome analyses with M. marinum, 
S. typhimurium, and E. tarda intravenous infection models using custom made Agilent 
micro-arrays and deep sequencing [19, 22-24]. The conventional infection method for 
zebrafish embryos is injection of pathogens into the caudal vein. However, this method 
is labour intensive and low throughput. For that reason we have recently developed and 
validated a high-throughput yolk infection model using M. marinum with an automated 
micro-injection system [12]. However, in this high-throughput model no transcriptome 
analysis has been performed until now. In the present study we have developed a high-
throughput system for quantitating infection with S. epidermidis using the automated 
micro-injection system together with Complex Object Parametric Analysis and Sorting 
(COPAS) technology. This quantitative high-throughput technology has been used 
to study the transcriptome responses during non-lethal infection progression of 
S. epidermidis over time using micro-arrays and RNA deep sequencing. In order to 
understand which responses can be linked to defence mechanisms of the zebrafish 
towards fish pathogens, we have compared the host responses to S. epidermidis and 
to M. marinum at a time point when the initial yolk infection has further spread into 
the embryo’s tissues. The obtained results allowed us to identify a number of genes as 
markers common for both infection models but also genes that can be used as markers 
to discriminate between pathogen specific responses.
Results and discussion
Pathogenesis of S. epidermidis and S. aureus in zebrafish embryos
We first set out to compare S. epidermidis infected zebrafish embryos with embryos 
infected with S. aureus. For this purpose we injected S. epidermidis O-47 and S. aureus 
RN4220 strains containing GFP or mCherry plasmids under the same conditions into 
the yolk of embryos at 2 hours post fertilization (hpf). Injections with 5 cfu of S. aureus 
already showed a high intensity of fluorescent bacteria inside the yolk at the first day 
after injection. At the second day after injection all embryos had died from infection 
with bacteria spread inside the entire body of the embryos (data not shown). Injection 
directly into the caudal vein at 28 hpf with approximately 2500 cfu resulted in 100% 
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mortality within several hours (data not shown). This high early mortality due to S. 
aureus is in accordance with earlier reports [20, 25, 26]. We subsequently tested S. 
epidermidis O-47 in yolk injections at doses of 5, 20, 50 or 100 cfu. At 1 day post injection 
(dpi) several small spots of fluorescent bacteria were observed inside the yolk with all 
cfu doses (Figure 1A), which were absent in mock-injected controls. From 2 dpi onwards, 
bacteria, indicated by their fluorescence signal, were visible inside the yolk in a dose-
depended fashion. The fluorescence signal became detectable inside the body of the 
embryos starting at 3 dpi (Figure 1A). From this day onwards the bacteria were persisting 
in the vascular system and within various tissues. Confocal laser scanning microscopy 
was used to obtain a detailed image of bacteria spreading into the different tissues at 3, 
4 and 5 dpi, the time points at which spreading of bacteria was observed (Figure 2). At 
3 dpi bacteria were found intracellularly and extracellularly in the hematopoietic region 
(Figure 2, panel 1), and free existing bacteria were observed in the blood were taken 
up by mpeg1:KAEDE positive cells (Figure 2, panel 4). Free staphylococci in the blood 
have also been observed after intravascular catheter-related infections [27, 28]. At 4 
dpi much more extracellular bacteria in the intersegmental vessels were seen (Figure 
2, panel 2). No differences were found between the patterns observed at 4 and 5 dpi 
(Figure 2, panel 3). Although there was strong increase of the bacterial burden in tissues 
and blood at 4 and 5 dpi (Figure 2 panel 2 & 3 and Supplementary file 1), in most cases 
embryos survived the 5 days infection period similar as the mock-injected controls. 
Cfu counts of homogenized pooled embryos revealed that S. epidermidis proliferated 
exponentially inside the embryos during the 5 days of infection (Figure 1B). Comparing 
the yolk injection method with the traditional caudal vein injection method showed 
that embryos injected with as much as 5000 and 10000 cfu of S. epidermidis into the 
caudal vein at 28 hpf did not develop any signs of infection. Fluorescence microscopy 
(See legend on next page)
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Figure 1. Quantitation of fluorescence intensity in S. epidermidis-injected embryos using the COPAS 
system. (A) Bright field /fluorescence overlay images of mCherry-labelled S. epidermidis. Wild type 
zebrafish embryos injected with 100 cfu of S. epidermidis O-47 into the yolk at 2 hpf were imaged at 5 time 
points from 1 to 5 dpi, scale bar is 250 μm. (B) Cfu counts of S. epidermidis-infected embryos. Groups of 
10 embryos were homogenized and plated directly after injection until 5 dpi. (C) The graphs represent the 
average fluorescence intensity from the entire group of non-injected and S. epidermidis-injected embryos, 
from 2 dpi until 5 dpi. An increase in fluorescence intensity is visible during this infection period. (Error bars 
= SEM). Different letters indicate statistical significant differences (P < 0.001). (D & E) Correlation between 
cfu counts and fluorescence intensity of embryos infected with mCherry-labelled (D) and GFP-labelled (E) 
bacteria. Pools of 10 infected embryos between 2 and 5 dpi were homogenized and plated. The average 
fluorescence intensity is plotted against the cfu count.
Figure 2: Invasion of S. epidermidis into the zebrafish embryo body. Confocal z-stacks are shown as 
transmission/fluorescence overlay (A & C) and fluorescence images (B & D). Panel 1: at 3 dpi mCherry 
labelled S. epidermidis is observed inside the body (1A &1B, scale bar: 50 μm), and intracellular in the 
hematopoietic region (1C & 1D, scale bar: 10 μm). Panel 2: at 4 dpi bacteria are found inside the vasculature 
(2A & 2B, scale bar: 50 μm), including the intersegmental vessels (2C & 2D, scale bar: 10 μm). Panel 3: at 
5 dpi bacteria are still persisting in the vasculature (3A & 3B, scale bar: 25 μm) and in the intersegmental 
vessels (3C & 3D, scale bar: 10 μm). (4A & 4B) bacteria being taken up by mpeg1:KAEDE positive cells and 
extracellular in the hematopoietic region at 3 dpi (scale bar: 10 μm).
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showed that all injected bacteria were cleared within several hours after injection (data 
not shown). In view of this, we conclude that the yolk infection system is therefore 
uniquely suitable to follow the proliferation of S. epidermidis and its effects on the host 
for at least 5 dpi. At the moment we can only speculate why the bacterial that were 
injected in the yolk had such better survival rates than bacteria injected in the caudal 
vein at later stages. Three possible explanations (or a combination of these factors) are 
that (1) there were repeated cycles of invasion from the yolk, (2) the bacteria in the yolk 
are primed to an infectious growth strategy for instance by using alternate sigma factors 
[29], or (3) the host immune system has been altered due to the prolonged exposure to 
high numbers of bacteria and possible associated anti-inflammatory compounds inside 
the embryos.
High-throughput infection quantification
The COPAS XL (Union Biometrica, USA) is a large cell flow cytometer designed for 
fluorescence screening of zebrafish embryos, Drosophila larvae and beads ranging from 
1500 to 2000 microns in diameter [12, 30]. Samples are analysed for size, optical density 
and three fluorescence signals. Groups of up to 3000 embryos can simultaneously be 
analysed and sorted into multi well plates or Petri dishes within 15 minutes (Figure 3). 
The Profiler software package II detects and analyses up to 8000 data points per object 
for the extinction and fluorescence channels, and can be used to visualize every sample 
or to set sorting parameters. The Profiler shows the outline of a sample together with all 
fluorescence intensity traces, for each of the embryos in a sample. This is exemplified by 
a typical experiment of S. epidermidis infection of zebrafish embryos measured at 4 dpi 
(Figure 3, panel B, and detailed in Supplementary file 2). COPAS analysis was performed 
every day from 2 dpi until 5 dpi. The daily analysis did not cause noticeable damage to 
the embryos. We observed an increase in the fluorescence signal during the 5 days of 
infection with S. epidermidis (Figure 1C). Cfu count results showed good correlation 
with the increase of fluorescence signal in pools of embryos infected with mCherry-
labelled (Figure 1D) or GFP-labelled (Figure 1E) bacteria. However, in the green channel 
some background signal produced by the embryonic yolk was detected, leading to less 
accurate quantification (Figure 1E). Since the red fluorescence channel did not show 
any background signal, the results with mCherry-labelled bacteria were quantitatively 
more reliable, showing a correlation with the cfu counts (Figure 1D). We did not find 
any influence of the orientation of the embryos in the flow chamber since we did not 
detect differences in embryos passing the laser dorsally or ventrally, or with the anterior 
or posterior side first. Therefore, our results show that combining the COPAS analysis 
with the automated micro-injection system provides a screening system of which the 
infection levels are statistically reliable.
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Figure 3. Workflow of high-throughput injection and subsequent analysis. (A) from left to right; a zebrafish 
pair are put together to mate, eggs are collected, eggs are distribute into a 1024 well agarose grid, eggs 
are injected into the yolk at 2 hpf using the automated micro-injection system. (B) from left to right; after 
injection, eggs are collected into Petri dishes and incubated at 28°C for a period of 5 days, COPAS analysis 
is performed on the S. epidermidis and non-injected embryos at 2, 3, 4 and 5 dpi. (C) from left to right; 
from all groups 20 embryos are snap frozen at 6 hpi, 1, 2, 3, 4 and 5 dpi for RNA isolation, amplification 
and Cy3 labelling, micro-array analysis against Cy5 labelled common reference and data analysis using 
Rosetta Resolver. (D) from left to right; validation of micro-array data was performed by RNAseq analysis of 
4 biological replicas of S. epidermidis infected embryos at 5 dpi.
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Specific marker genes for S. epidermidis infection
To characterize the transcriptome response of zebrafish embryos following S. epidermidis 
yolk injection, we performed a time resolved infection experiment using the high-
throughput set up (Figure 3). Considering that all bacterial injections were carried out 
with polyvinylpyrrolidone40 (PVP) as carrier, PVP-injected embryos were taken along to 
control for possible effects of the carrier. Furthermore, needle puncture treated and 
non-injected embryo groups were included as additional control groups. Injections 
were performed with groups of at least 150 embryos of the same parents of which 
sets of 20 embryos were sampled during 6 time points (Figure 3). In order to check for 
reproducibility of this experiment an independent experiment was performed with the 
same parents at 4 dpi. RNA from these samples was used for micro-array analysis using 
custom made Agilent 4x180k micro-arrays.
Principal component analysis showed a clear signature progression in time of all 
samples (Supplementary file 3). Results of statistical analyses are presented in the Venn 
diagrams of Figure 4. Comparing each time point with multiple control samples clearly 
shows that there is a false negative effect in the controls that can be corrected for by 
using the overlap of the ratios of the different controls. This led to a filtered dataset 
as used for Figure 5 as discussed below. However, we want to emphasize that the 
injection of PVP has a reproducible effect by itself (Figure 4). This could be of relevance, 
especially considering the effect of biomaterials on infection capacity of S. epidermidis 
in patients that make it worthwhile to further analyse the effect of PVP on infection in 
future experiments. We have analysed the effect of S. epidermidis infection over time 
on gene expression using Unigene clusters and ENSEMBL codes as specified in the raw 
data table of Supplementary file 4. Annotation of these probes by Gene Ontology (GO) 
shows that the most noticeable result is that S. epidermidis does induce many immune-
related genes starting from 3 dpi, observing a maximum induction of their expression at 
4 dpi. Filtering the results (Figure 5) we found an effect on the expression levels of many 
genes in the earliest measured time point (6 hpi) after exposure to injected bacteria. 
This effect is diminished to only a few genes whose expression is affected at the time 
point of 2 dpi, most of which cannot be assigned to a GO category (Figure 4). At 6 hpi, GO 
analysis indicated very broad classes of gene functions whose expression are affected 
by infection but did not reveal an obvious link to the immune response since the broad 
GO category “immune response” was not represented. At this stage the known innate 
immune responses to bacterial infection are not yet apparent. For instance neutrophils 
and macrophages have not yet developed and nothing is known about the function of 
pattern recognition receptors before this stage. We are currently studying the function 
of the expressed Toll-like receptors during early stages of embryogenesis [31]. We have 
manually annotated various functional categories of genes, of which the transcription 
levels were strongly affected by infection during time as shown in Figure 5 in a schematic 
representation and in Supplementary file 5 in a quantitative manner. Many of the 
immune genes indicated in Figure 5 have been previously linked to expression in cells 
73
4
(See legend on next page)
74
4
of the myeloid lineage in zebrafish [32]. The immune transcriptome response correlates 
with the infection progression as described above. The first 3 days, the bacteria 
accumulate inside the embryonic yolk. This apparently does not lead to significantly 
induction or repression of many immune-related genes. From 3 dpi onwards many 
immune-related genes were significantly induced with a peak at 4 dpi (Figure 5). At 5 
dpi there were slightly less immune-related genes significantly expressed than at 4 dpi. 
Expression levels of the 49 selected genes shown in Figure 4 at 5 dpi were also lower 
compared with 4 dpi (Supplementary file 5). Since the analysed larvae were from the 
same injected batch it seems that higher microbial burden is not strictly correlated with 
a stronger immune response. Validation of this micro-array experiment was performed 
by deep sequencing analysis of RNA samples derived of 4 batches of approximately 150 
embryos at the 5 day time point of infection and 4 non-infected batches of embryos. 
The data confirms the micro-array data as exemplified for some of the most reliable 
probes (Table 1). Furthermore we have compared the normalized reads per kilobase per 
million mapped reads (RPKM) [33] for the genes shown in Figure 5. These comparisons 
show that only in a few cases there are discrepancies between the results of the two 
technologies. Since the RNA deep sequencing results are obtained with a pool of larger 
number of biological samples, this could indicate that in these cases the micro-arrays 
result are less trustworthy. However, it was noted that in cases of discrepancy there 
were extremely low levels of expression resulting in a very limited number of mapped 
reads, showing that even with a sequencing depth of at least 20 million reads per sample 
there is still a limitation of sensitivity of RNA sequencing. This is of note because in most 
publications currently a sequence depth of 20 million reads is standard for RNA deep 
sequencing [34, 35]. In several cases, such as il8, there was no ENSEMBL annotation 
of the gene that could be used for RPKM analysis. We have manually quantified the 
number of reads mapping to il8 to show that there is also induction after infection as in 
the case of the micro-array analysis (Figure 6). RNA deep sequencing provides a much 
more detailed insight in gene regulation for instance showing also expression levels for 
every exon of the genes as shown for the representative genes mmp9 and il8 (Figure 6). 
With the expected progress in development of high-throughput bioinformatic pipelines 
for data visualization of RNA sequencing data sets, we and others will be able in the near 
future to further harvest information from our submitted expression datasets as to the 
effects of infection on differential splicing, transcription start sites or polyadenylation 
sites in the entire transcriptome.
(see Figure on previous page)
Figure 4. Overlapping probes in time from micro-array analysis. The Venn diagrams show the number of 
significantly up-regulated probes (top row) or down-regulated probes (bottom row) (P-value smaller than 
10-8 and fold changes larger than 2 or smaller than -2) between S. epidermidis injected versus non-injected, 
S. epidermidis injected versus needle puncture and S. epidermidis injected versus PVP at 6 hpi, 1, 2, 3, 4 
and 5 dpi. Data at 4 dpi are based on a biological replica. Pie diagrams represent GO annotation using 




Figure 5. Gene expression during S. epidermidis infection. Micro-array data are shown of S. epidermidis-
injected versus non-injected samples at 6 hpi, 1, 2, 3, 4 and 5 dpi time points. The yellow boxes represent 
up-regulation and the blue boxes down-regulation with a P-value smaller than 10-8 and fold changes larger 
than 2 or smaller than -2. The top right bar shows the RNA deep sequencing data, where the green boxes 
represent significant up-regulation. The white boxes could not be identified by RNA deep sequencing. Grey 
boxes mean that data did not meet the significant criteria. Genes were manually annotated and assigned 
to functional groups based on GO annotations of the zebrafish genes and their human homologues and 
on searching on PubMed abstracts. The D. rerio Uni-Gene Build # 124 or ENSEMBL Zv9 codes were used as 
shown with the raw data table in Supplementary file 4).
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Comparison of transcriptome responses to S. epidermidis and M. marinum
In order to compare the transcriptional response observed in zebrafish embryos 
infected with S. epidermidis with the response triggered by a pathogenic bacterium, we 
also performed an injection experiment with M. marinum using the same experimental 
protocol and sampling at 5 dpi. This time point was chosen in order to make it 
comparable to previous studies in which the caudal vein was used as the injection site 
[23]. We performed micro-array analysis, confirming the biological relevance of the yolk 
injection system since many markers that were previously identified to be differentially 
expressed in the caudal vein injection system [23] appeared regulated in a similar 
manner in the high-throughput yolk infection system (Figure 7 and Supplementary file 
6). We observed a stronger transcriptional response of immune related genes than 
what we observed with caudal vein administration, which can be explained by the fact 
that bacteria accumulated more strongly after five days compared to the caudal vein 
injection method and have been present one more day inside the embryos. A number 
of the immune markers identified to be differentially expressed after infection with S. 
epidermidis appeared regulated in the same way after M. marinum yolk infection. These 
include the matrix metalloproteinases, complement factors, cytokines and heat shock 
proteins that were previously also identified in M. marinum infection in the caudal vein 
[23]. There are also distinct differences in genes responding to infection by these two 
different bacteria. Most obvious is a stronger transcriptional response of a number of 
relevant genes to M. marinum than to S. epidermidis infection. Interestingly, there is 
also a category of genes that are highly regulated by S. epidermis but not significantly 
by M. marinum in the yolk infection model. These genes include various immune 
related genes such as il8, il12a, tnfb, lect2l, and transcription factor atf3, junba, junbb, 
Gene Sample Micro-array RNA deep sequencingFold change P-value Fold change P-value
atf3 S. epidermidis versus 
non-injected (5 dpi)
+ 2.83 2.49x10-09 + 4.77 1.83x10-44 
cxcl-c1c S. epidermidis versus 
non-injected (5 dpi)
+ 5.77 1.77x10-14 + 6.74 4.07x10-25 
HPX (1 of 2) S. epidermidis versus 
non-injected (5 dpi)
+ 10.10 1.60x10-11 + 6.00 1.13x10-51 
il1b S. epidermidis versus 
non-injected (5 dpi)
+ 11.94 1.22x10-10 + 8.54 9.97x10-38 
lect2l S. epidermidis versus 
non-injected (5 dpi)
+ 6.99 1.80x10-20 + 3.12 1.17x10-21 
mfap4 (4 of 13) S. epidermidis versus 
non-injected (5 dpi)
+ 21.27 4.15x10-41 + 3.67 4.30x10-09 
mmp9 S. epidermidis versus 
non-injected (5 dpi)
+ 5.18 9.73x10-20 + 10.71 1.54x10-95 
mmp13a S. epidermidis versus 
non-injected (5 dpi) 
+ 7.35 1.07x10-18 + 15.30 6.03x10-82 
 
Table 1 Validation of micro-array data by RNA deep sequencing analysis. Shown are 8 representative 




Figure 6. Expression levels of individual exons. All exons of mmp9, il8, lect2l, mfap4 (4 of 13) and atf3 were 
significant induced at 5 dpi following yolk infection with S. epidermidis. M. marinum yolk infection at the 
same time point only resulted in induction of all mmp9 exons.
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Figure 7. Gene expression during M. marinum E11 infection. Micro-array data is shown for the infection of 
M. marinum at 5 dpi at the left side of each gene. The yellow boxes represent up-regulation and the blue 
boxes down-regulation with a P-value smaller than 10-8 and fold changes larger than 2 or smaller than -2. 
Probes with unchanged expression are indicated in grey. RNA deep sequencing data is shown for the same 
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irf7, irf1b and cebpb. However, in pilot micro-array studies where higher numbers of 
mycobacteria were injected, some of the markers were also induced or repressed with 
the exception of il12a and cebpb (data not shown). For M. marinum infection we observe 
some difference of gene regulation after yolk infection as compared to caudal vein 
injection. For instance, atf3 is up-regulated in the latter system (unpublished results). 
One of the examples of genes induced specifically by S. epidermidis in the yolk infection 
system has high similarity to the mammalian microfibril-associated glycoprotein 4-like 
isoform 1 gene (mfap4-like isoform 1, Unigene accession number Dr.149043, also called 
mfap4 (4 of 13) in ENSEMBL) which has been identified previously by Schlosser et al. 
[36] to bind to human Surfactant protein A (SP-A). Interestingly SP-A is a good marker 
for clearance of S. aureus since it is involved in binding to the staphylococcal adhesion 
extracellular adherence protein as well to the macrophage receptors SP-A receptor 
210 and scavenger receptor class A, enhancing phagocytosis [37]. There are over 13 
homologs of this gene clustered in a region on chromosome 1 that are extremely similar 
but not all inducible by S. epidermidis infection. Therefore we aim to further investigate 
specificity of induction of these genes by microbial infection in follow up studies. We 
also performed a RNA sequencing experiment of the M. marinum infection system at 
5 dpi for verification of the micro-array data. These data show that all exons of mfap4 
(4 of 13), atf3 and lect2l tested are significantly expressed at 5 dpi by S. epidermidis, 
whereas after M. marinum infection there is no significant expression of these exons. 
With mmp9 as a positive control, the expression of all exons is significantly expressed 
after M. marinum infection (Figure 6). The expression levels for mfap4 (4 of 13) are 
based on manual annotation of the unique reads in the known gene region since there 
are several repetitive DNA regions in common with the other 12 annotated mfap4 gene 
family members (Figure 6). Here we clearly benefit from the power of RNA sequencing 
that can overcome the problems of micro-array probe annotation for complex gene 
families. Therefore using our unbiased approach we were able to confirm known 
immune genes as markers for staphylococci infection but also identify novel markers as 
good candidates for specific response markers of S. epidermidis in our infection model 
that we will study further in functional analysis in the near future.
Conclusions
Microscopic imaging showed that S. epidermidis when injected into the yolk or caudal 
vein proved to be far less virulent than S. aureus. Under the same conditions of yolk 
injection S. aureus immediately invades the body of embryo causing 100% mortality 
within 3 dpi. In contrast, during the five day time period analysed, S. epidermidis 
proliferates efficiently in the entire body of the infected embryos providing an excellent 
sample at the right side of each gene. Green boxes represent up-regulation and the purple boxes down-
regulation with a P-value smaller than 0.02 and fold changes larger than 2 or smaller than -2. Genes were 
manually annotated and assigned to functional groups based on GO annotations of the zebrafish genes 
and their human homologues and on searching on PubMed abstracts. The D. rerio Uni-Gene Build # 124 or 
ENSEMBL Zv9 codes were used as shown with the raw data table in Supplementary file 6).
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system for analysis of factors that influence bacterial proliferation and virulence. Based 
on this advantage, we have developed a versatile high-throughput analysis system for 
bacterial proliferation that is much less time consuming than cfu count determinations, 
and which allows repeated measurements of the same embryos over time. COPAS 
analysis proved to be accurate to determine the bacterial burden inside embryos at 
high-throughput. With addition of sorting zebrafish embryos into multi well plates, for 
automated confocal laser scanning microscopy, a medium-throughput, high-resolution 
screenings system can be added. We therefore have extended the high-throughput 
infection methods developed by Carvalho et al. [12] to a quantitative level and showed 
the applicability for the analysis of proliferation of opportunistic pathogens such as S. 
epidermidis. Our over time transcriptome analysis results correlate very well with the 
infection pattern of S. epidermidis. The bacteria will grow for the first 2 to 3 days inside 
the yolk of the embryos, while from 3 and 4 dpi S. epidermidis invade the body of the 
embryo, at which stage a strong response of many immune related genes occurs. We 
have compared transcriptome response in the same system using M. marinum. These 
comparisons show that M. marinum has a far stronger effect on host gene regulation 
than S. epidermidis. However, some genes were identified that specifically responded 
to S. epidermidis and not to M. marinum infection including a cell adhesion gene 
(mfap4, ENSEMBL 4 of 13) that can be linked to specific infection by staphylococci in 
mammals. Vuong et al. [38] and Otto et al. [26] already reported that S. epidermidis 
itself does not seem to have particular specific virulence factors. All known putative 
virulence factors have origins in the commensal lifestyle of this species. However, the 
large difference between the outcome of injection of bacteria into the yolk or caudal 
vein could have been caused by an effect of prolonged growth of the bacteria in the host 
organism resulting in a higher virulence when the bacteria are release in other tissues. 
In our future research we aim to use our identified host marker genes to identify new 
bacterial traits involved in proliferation in host tissues and the factors that determine 
their expression during time with emphasis on the time points when bacteria get in 
contact with immune cells. We are particularly interested in the effect of biomaterials 
on possible virulence factors that make virulence deviate from the commensal life style. 
This can help to understand which host mechanisms and genes are involved during 
biomaterial-associated infections.
Material and methods
Bacterial strains and growth conditions
S. epidermidis strain O-47, containing the GFP expression vector pWVW189 or a derived 
mCherry expression vector (De Boer L. unpublished) and S. aureus strain RN4220 
pWVW189 (De Boer L. unpublished) from LB (Luria Bertani) agar plates were cultured 
overnight at 37°C in 25 ml LB medium supplemented with 10 μg/ml chloramphenicol 
to mid-log stage. M. marinum strain E11 was grown as described in Carvalho et al. [12]. 
Two reaction vials with 1 ml of the culture were centrifuged at 14680 rpm for 1 min. 
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The pellets were combined and washed three times with 1 ml PBS. Suspensions were 
prepared based on the OD600 and by plating and cfu determination. The inocula were 
suspended in 2% polyvinylpyrrolidone40 (PVP40, CalBiochem) to 5.0×10
6, 1.0×108 cfu/ml.
Zebrafish husbandry
Zebrafish were handled in compliance with animal welfare regulations and maintained 
according to standard protocols (http://ZFIN.org). Embryos were grown at 28°C in egg 
water (60 μg/ml Instant ocean sea salt, Sera Marin). The egg water was refreshed every 
day. 
Experimental design of infection study
Infection experiments were performed using mixed egg clutches from wild type AB×TL 
or Tg(UAS:KAEDE/MPEG1:GAL4) strain zebrafish [15]. Embryos were staged at 2 hpf 
by morphological criteria, and 20 cfu of mCherry or GFP expressing S. epidermidis 
O-47 bacteria suspended in 2% PVP40 were injected into the yolk. As a control an equal 
volume of 2% PVP40 was likewise injected. Manual injections were controlled using a 
Leica M50 stereomicroscope together with a FemtoJet micro-injector (Eppendorf) and 
a micromanipulator with pulled micro capillary needles. Automated micro-injections 
were performed as described in Carvalho et al. [12].
Microscopy
A Leica fluorescence (MZ 16 FA) stereo microscope and Leica TCS SPE confocal 
microscope were used to take images of zebrafish embryos. Embryos were kept under 
anaesthesia (0.02% buffered 3- aminobenzoic acid ethyl ester (Tricaine, Sigma) in egg 
water) during imaging.
COPAS analysis
Zebrafish embryos were measured alive every 24 hours until 5 dpi with the COPAS XL 
using the setting as described below. Photo multiplier tubes (PMT) voltage: 650 V for 
green/red and 0 V for yellow. Optical density threshold signal was set to 975 mV (COPAS 
value: 50) and the time of flight (TOF) minimum to 320 μs (COPAS value: 800) in order 
to reduce the influence of debris.
Cfu count
Injected embryos were collected into a 2 ml reaction vial with a sterile 5 mm stainless 
steel bead and PBS. The reaction vials were vigorously shaken for 30 seconds at 30 
revolutions per second in a shaker (Retsch MM301). All suspensions were diluted, plated 
in duplicate on LB agar supplemented with 10 μg/ml chloramphenicol, and incubated 





Seven parent zebrafish couples kept separately from one another for mating the 
following week, to perform an identical experiment for a biological replicate. Injections 
were performed from the 16 cell stage onwards at approximately 2 hpf: the first group 
was injected with 1 nl 2% PVP40 solution containing 20 cfu/nl S. epidermidis O-47 
pWVW189, the second group with 1 nl 2% PVP40 solution without bacteria, the third 
group only received a needle puncture in the yolk, and the last group was a non-injected 
control group. Groups consisted of approximately 150 embryos. The S. epidermidis 
O-47 pWVW189-injected group and the non-treated embryos were measured at 2, 3, 4 
and 5 dpi with the COPAS XL just before snap freezing. At 6 hpi, 1, 2, 3, 4 and 5 dpi, 20 
embryos were collected randomly from each group, snap frozen in liquid nitrogen, and 
stored at −80°C. Embryos were homogenized in 0.5 ml of TRIzol reagent (Invitrogen), 
and total RNA was extracted according to the manufacturer’s instructions. RNA samples 
were treated with DNaseI, (Ambion) to remove residual genomic DNA. RNA integrity 
was analysed by Lab-on-a-chip analysis (Agilent). The average RIN value of the RNA 
samples was 8.1 with a minimum of 6.7. Per sample, 500 ng total RNA was combined 
with Spike A and amplified according to the Agilent Two-Color Micro-array-Based Gene 
Expression Analysis guide version 5.5 (G4140-90050, Agilent technologies). For the 
common reference an equimolar pool of all test samples was made and 500 ng samples 
were amplified similarly as the test samples with the exception that Spike B was used. 
Amino-allyl modified nucleotides were incorporated during the aRNA synthesis (2.5 
mM rGAC (GE Healthcare), 0.75 mM rUTP (GE Healthcare), 0.75 mM AA-rUTP (TriLink 
Biotechnologies). Synthesized aRNA was purified with the E.Z.N.A. MicroElute RNA 
Clean Up Kit (Omega Bio-Tek). The quality was inspected on the BioAnalyzer (Agilent 
Technologies) with the Agilent RNA 6000 kit (5067–1511, Agilent Technologies). Test 
samples were labelled with Cy3 and the Reference sample was labelled with Cy5. For 
mycobacterium infected embryos a dye swap technical duplicate was performed in 
which the control was either labelled with Cy3 or Cy5. The overlap of the technical 
duplicates was used for the output files. Five μg of aRNA was dried down and dissolved 
in 50 mM carbonate buffer pH 8.5. Individual vials of Cy3/Cy5 from the monoreactive 
dye packs (GE Healthcare) were dissolved in 200 μl DMSO. To each sample, 10 μl of 
the appropriate CyDye dissolved in DMSO was added and the mixture was incubated 
for 1 h. Reactions were quenched with the addition of 5 μl 4 M hydroxylamine (Sigma-
Aldrich). The labelled aRNA was purified with the E.Z.N.A. MicroElute RNA Clean Up Kit. 
Yields of aRNA and CyDye incorporation were measured on the NanoDrop ND-1000.
Each hybridization mixture was made up from 825 ng Test (Cy3) and 825 ng Reference 
(Cy5) material. Hybridization mixtures were made as described in the Agilent Two-Color 
Micro-array-Based Gene Expression Analysis guide version 5.5 (G4140-90050, Agilent 
technologies). The samples were loaded onto 4x180k D. rerio micro-arrays (Design 
ID:028233, Agilent Technologies) and hybridized for 17 hours at 65°C. Afterwards the 
slides were washed and scanned (20 bit, 3 μm resolution) in an ozone-free room with 
the Agilent G2505C scanner as described in the Agilent Two-Color Micro-array-Based 
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Gene Expression Analysis guide version 5.5 (G4140-90050, Agilent technologies). 
Data was extracted with Feature Extraction (v10.7.3.1, Agilent Technologies) with the 
GE2_107_Sep09 protocol for two-color Agilent micro-arrays. Micro-array data was 
processed using Rosetta Resolver 7.2 (Rosetta Biosoftware). S. epidermidis infection 
groups were compared to the PVP, needle puncture and non-injected control groups 
using the Rosetta common reference re-ratio experiment pipeline. Significance cut off 
for the ratios of S. epidermidis versus PVP, S. epidermidis versus needle puncture and 
S. epidermidis versus non-injected were set at 2 fold change at P-value smaller than 
10-8. Pathway analysis was performed using the Pathvisio software package (www.
pathvisio.org) [39] with the same significance cut off. The raw micro-array data have 
been deposited in the NCBI GEO database under accession number GSE42847 and 
GSE44352. DAVID bioinformatics resources 6.7 [40, 41] was used for gene ontology 
analysis.
RNA deep sequencing
Validation of micro-array data was performed by RNAseq analysis. Ten parent zebrafish 
couples were kept separately from one another for mating the following week, to 
perform an identical experiment for 4 biological replicates. Injections were performed at 
approximately 2 hpf using the automated micro-injection system. At 5 dpi, embryos were 
collected from the 2 hpf injected and non-injected group, snap frozen in liquid nitrogen, 
and stored at −80°C for RNA isolation. Twenty cfu of S. epidermidis O-47 pWVW189 
were injected to obtain 150 embryos per sample. For M. marinum infected embryos 
approximately 1000 embryos were used with 30 cfu injected per embryo. Embryos 
were homogenized in 1 ml of TRIzol reagent (Invitrogen), and total RNA was extracted 
according to the manufacturer’s instructions. RNA samples were treated with DNaseI, 
(Ambion) to remove residual genomic DNA. RNA integrity was analysed by Lab-on-a-chip 
analysis (Agilent). The average RIN value of the RNA samples was 9.7 with a minimum of 
9.5. A total of 3 μg of RNA was used to make RNA-Seq libraries using the Illumina TruSeq 
RNA Sample Preparation Kit v2 (Illumina Inc., San Diego, USA). In the manufacturer’s 
instructions two modifications were made. In the adapter ligation step 1 μl instead of 
2.5 μl adaptor was used. In the library size selection step the library fragments were 
isolated with a double Ampure XP purification with a 0.7x beads to library ration. The 
resulting mRNA-Seq library was sequenced using an Illumina HiSeq2000 instrument 
according to the manufacturer’s description with a read length of 2 × 50 nucleotides. 
Image analysis and base calling was done by the Illumina HCS version 1.15.1. Sequence 
reads were quality trimmed using the quality_trim module in the CLCbio Assembly Cell 
v4.0.6. Filtered reads were mapped to ENSEMBL transcripts (Zv9_63) using the ref_
assemle_short module in the CLCbio Assembly Cell v4.0.6. Accumulation of transcripts 
to ENSEMBL genes was done by first converting the mapping files to a table with the 
assembly_table module in the CLCbio Assembly Cell v4.0.6. Secondly, a custom script 
was used that sums all reads belonging to the same gene. Non-uniquely mapped reads 
were divided between genes according to their ratio of uniquely mapped reads. Finally, 
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read counts of transcripts belonging to the same gene were summed to obtain count 
data at ENSEMBL gene level. Fold-change and differential expression significance values 
were calculated from gene level read counts using the DESeq package version 1.8.3) 
available in Bioconductor (version 2.10). DESeq utilizes a negative binomial distribution 
for modelling read counts [42]. Secondly reads were counted per exon with a python 
script (Lodder R. unpublished). Sorted sam files were obtained from the raw fastq files 
through Bowtie2 [43] and samtools [44]. The raw RNAseq data have been deposited in 
the NCBI GEO database under accession number GSE42847 and GSE44352.
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We present a RNA deep sequencing (RNAseq) analysis of a comparison of the 
transcriptome responses to infection of zebrafish larvae with Staphylococcus epidermidis 
and Mycobacterium marinum bacteria. We show how our developed GeneTiles 
software can improve RNAseq analysis approaches by more confidently identifying 
a large set of markers upon infection with these bacteria. For analysis of RNAseq 
data currently software programs such as Bowtie2 and Samtools are indispensable. 
However, these programs that are designed for a LINUX environment require some 
dedicated programming skills and have no options for visualization of the resulting 
mapped sequence reads. Especially with large data sets this makes the analysis time 
consuming and difficult for non-expert users. We have applied the GeneTiles software 
to the analysis of previously published and newly obtained RNAseq datasets of our 
zebrafish infection model and we have shown the applicability of this approach also to 
published RNAseq datasets of other organisms by comparing our data with a published 
mammalian infection study. In addition we have implemented the DEXSeq module in 
the GeneTiles software to identify genes, such as glucagon A, that are differentially 
spliced under infection conditions. In the analysis of our RNAseq data this has led 
to the possibility to improve the size of data sets that could be efficiently compared 
without using problem-dedicated programs, leading to a quick identification of marker 
sets. This approach will therefore also be highly useful for transcriptome analyses of 
other organisms for which well-characterized genomes are available. Based on the 
transcriptome analysis we have analysed the function of the leptin b gene that was 
identified as the most highly induced gene after infection. Using metabolomics analyses 
we have shown that infection with M. marinum results in a rapid wasting syndrome. 
Results of gene knock-down analysis suggest that the leptin b gene is essential for 
progression of the wasting syndrome after bacterial infection.
Introduction
In our previous research we have used zebrafish larval infection models to study the 
transcriptome response to infection by several pathogens [1-5]. In addition we have 
tested the response of zebrafish larvae to infection by the opportunistic bacterium 
Staphylococcus epidermidis as a model for biomaterial-associated infections that are 
often caused by this species in clinical practice [6-9]. These studies have led to a high-
throughput model that resulted in a large set of RNAseq data sets highlighting a new 
bottleneck in our research: the fast and user-friendly analysis of large datasets that can 
be easily visualized for comparative purposes. 
In the analysis of our former transcriptome data sets there was a need for specialized 
scripting languages to quickly find good marker genes for disease. We used an existing 
visualization program, Integrative Genomics Viewer (IGV) [10] that shows the data 
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solely along a line representing the genome, thereby requiring zooming in to view 
the aligned reads. IGV, and many other open source visualization programs such as 
MapView [11], Tablet [12], GenoViewer [13] and BamView [14] also require the user to 
scroll or manually search for other genes to bring these into focus and an overview of 
a selection of genes based on alignment results is not available. Finally, most of these 
data visualization programs do not allow for export of presented visual results, other 
than taking screenshots. In our previous analysis of RNAseq data we were reliant on 
manual counting of reads as guided by the Integrative GenomeViewer [1]. 
In this paper we used the transcriptome data set obtained from the zebrafish high-
throughput screening system for S. epidermidis infection [1] as a case study to optimize 
and automate the data analysis pipeline. Using the resulting software package we 
also went further and added a larger RNAseq data set from Mycobacterium marinum 
infection data for comparisons of specificity of the transcriptome responses. We also 
integrated the DEXSeq algorithm that can be used to give an estimate of probability 
of the occurrence of differential splicing. This has led to the identification of genes 
that are differentially spliced after microbial infection in zebrafish larvae. Finally, we 
wanted to include a comparison with whole organism infection data in other vertebrate 
species. Unfortunately, there is still few RNAseq data for this available that can be 
mapped on ENSEMBL genome data and as a result we have only been able to compare 
our zebrafish infection data with RNAseq data from a bovine digital dermatitis (BDD) 
model as published by Scholey et al. 2013 [15]. However, the results are sufficient to 
show that our approach makes also such interspecies comparisons of RNAseq datasets 
very easy and can quickly lead to conclusions on conserved immune responses, even in 
comparisons between very different fish and mammalian infection models. One of the 
genes conserved between fish and mammals and highly induced by infection encodes 
the hormone leptin b and we selected this gene for functional analysis in this study.
Material and methods
Bacterial strains and growth conditions
The S. epidermidis strain O-47 containing a pWVW189 derived mCherry expression 
vector (De Boer L. unpublished) was grown as described in Veneman et al. (2013). The 
M. marinum strain E11 was grown as described in Carvalho et al. 2011 [16]. Two reaction 
vials with 1 ml of the culture were centrifuged at 14680 rpm for 1 min. The pellets 
were combined and washed three times with 1 ml phosphate-buffered saline (PBS). 
Suspensions were prepared based on the optical density at 600 nm and by plating and 
cfu determination. The inoculates were suspended in 2% polyvinylpyrrolidone40 (PVP40, 




For morpholino knock-down experiments, morpholino oligonucleotides (Gene Tools) 
were diluted to 0.5mM in nuclease free water. To block leptin b we used an ATG 
morpholino (5’- TTTTTTGCTTGTTAATATCATCCCT-3’). Embryos injected with leptin b 
morphlino were staged between the 16 and 128 cell stage and injected with 50 cfu 
of mCherry expressing M. marinum E11 bacteria suspended in 2% PVP40. Embryos 
were screened at 3, 4 and 5 dpi for bacterial proliferation using the COPAS XL (Union 
BioMetrica) flow cytometer as described in Veneman et al. (2013).
Metabolic profiling
Samples for mass spectrometry were taken at 4 and 5 dpi. Eight embryos per group 
were collected into a 1.5 ml reaction vial. All egg water was removed and the embryos 
were washed 2 times with 200 µl Millipore water. Per sample 80 µl of stock C (table 




1  MeOH I.S. Carnithine 
stock (table 2) 
I.S. Amine stock 
(table 3) 
Glucose-d7 5.5mM 
















  Step 1: stock 
7.3.1.2 
Step 2: Spike solution 7.3.1.3 
 Internal STD’s (1mg/ml) µl µg/m
l 
µl µg/ml µM 
1 Carnitine-d3 HCL   20 2.00 9.996 
2 Deoxycarnitine-d9 HCL   10 2.00 10.487 
3 Choline-d4 HCL   10 2.00 13.923 
4 Betaine-d3 HCL   20 2.00 12.769 
5 Acetyl-L-carnitine-d3 HCL   10 2.00 8.240 
6 Butyryl-L-carni 10 12.5  0.025 0.092 
7 Octanoyl-L-carnitine-d3 HCL 10 12.5  0.025 0.076 
8 Octadecanoyl-L-carnitine-d3 
HCL 
10 12.5  0.025 0.054 
 Stock solution 7.3.1.2   20   
 MeOH 770  9910   














Internal Standard Conc. (mg/ml) Solvent 
L-Ornithine D6 1 H2O 
Beta-Alanine D4 1 H2O 
L-2-aminobutyric acid d6 1 H2O 
2-(4-hydroxy-3methoxyphenyl)ethyl-1,1,2,2-D4-amine 1 H2O 
L-NT-Methyl-D3-L-Histidine 1 H2O 
L-3-(4-Hydroxy-3methoxy-D3-phenyl)alanine 1 H2O 
U-C13n15 cell free AA mix 0.875 H2O 
Ethanolamine-d7 1 H2O 
DL-Homocysteine-d4 1 H2O 
1.4-Butane-d8-diamine (Putrescine) 1 H2O 
 
Ratio: 1 ml labeled amino acid mix: 40 µl all other amine standards, in a total volume of 10 ml in MeOH.
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sonicated for 2 minutes at 40 kHz continuously changing positions in order for local 
sweet spots in the sonicator. The freeze-sonicate cycle was repeated 3 times. The lysate 
was vortexed for 5 seconds after which they were centrifuged for 5 minutes at 4 ˚C at 
16.1 krcf. Per sample 75 µl supernatant was collected and 8 µl supernatant was collected 
for quality control. The samples were evaporated using speedvac for 1 hour until they 
were completely dry. All samples were stored at -80 ˚C. Samples were defrosted in 30 
minutes and per sample 40 µl borate buffer was added and vortexed. Per sample 10 
µl AccQ-Tag (3 mg/ml) (Waters BV) reagent was added for derivatization. The samples 
were incubated at 55 ˚C for 10 minutes and were quickly spun down for 2 seconds after 
which they were diluted 4 times using H2O.
Mass spectrometry data processing
After Liquid Chromatography mass spectrometry (LC-MC) data acquisition, the data 
was processed in order to extract the proper target and internal standards (I.S.) peak 
area as follows. First, an Xcalibur (Thermo Fischer) Processing setup was generated in 
which all the targets and I.S. are identified (in terms of retention time and exact mass) 
from one of the QC samples and validated with the system suitability test (SST). Per 
batch the peak separation and retention time was checked and integrated into the 
processing setup. When every metabolite was correctly assigned and identified in the 
processing setup, the whole batch was analysed in the Xcalibur Quan browser. All peaks 
were integrated and manually checked in the Xcalibur Quan browser. When peaks were 
bad (i.e. bad peak shapes due to e.g. low concentration), the target was discarded from 
the study. From all the remaining targets the relative standard deviation (RSD) was 
calculated within all the QCs. Metabolites with RSDs above 20% were discarded from 
the study. On the remaining high-quality, normalized metabolite data set, univariate 
and multivariate analysis was performed. For the multivariate analysis, a principle 
component analysis (PCA) was used as a data exploratory tool [17]. For the univariate 
analysis, t-tests or ANOVAs were used.
Zebrafish husbandry
Zebrafish were handled in compliance with animal welfare regulations and maintained 
according to standard protocols (http://ZFIN.org). Embryos were grown at 28°C in egg 
water (60 μg/ml Instant ocean sea salt, Sera Marin). The egg water was refreshed every 
day.
Experimental outline
Infection experiments were performed with mixed egg clutches from wild type ABxTL 
strain zebrafish. Embryos were staged at 2 hours post fertilization by morphological 
criteria, and 20 cfu of mCherry expressing S. epidermidis O-47 or 30 cfu of mCherry 
expressing M. marinum E11 bacteria suspended in 2% PVP40 were injected into the 
yolk. Automated micro-injections were performed as described in Carvalho et al. [16]. 
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At 5 days post fertilization, embryos (N ~100) were collected from the 2 hours post 
fertilization injected and non-injected group, snap frozen in liquid nitrogen, and stored 
at −80°C for RNA isolation.
RNA deep sequencing
RNA isolation was performed as described in Veneman et al. (2013). A total of 3 μg 
of RNA was used to make RNAseq libraries using the Illumina TruSeq RNA Sample 
Preparation Kit v2 (Illumina Inc., San Diego, USA). In the manufacturer’s instructions 
two modifications were made. In the adapter ligation step 1 μl instead of 2.5 μl adaptor 
was used. In the library size selection step the library fragments were isolated with 
a double Ampure XP purification with a 0.7x beads to library ration. The resulting 
mRNAseq library was sequenced using an Illumina HiSeq2000 instrument according to 
the manufacturer’s description with a read length of 2 × 50 nucleotides. Image analysis 
and base calling was done by the Illumina HCS version 1.15.1. The raw RNAseq data 
have been deposited in the NCBI GEO database with accession number GSE42846, 
GSE44351 and GSE57792.
Data analysis
GeneTiles was used for quantification and visualization of the RNAseq data. When 
using GeneTiles, the complete data processing pipeline, including the used parameters 
is available for download. This enables the user to perform the same analysis locally, 
or try small modifications (for bioinformaticians). Here we give a quick list of the 
used programs and their function within our current pipeline. A detailed explanation 
including the used parameters is available in Supplementary file 2.
In order of use in GeneTiles:
1. Bowtie2 [18] is used to align the reads in the fastq file to the genome (obtained 
from Ensembl). Bowtie2 generates SAM files that contain the reads together with 
the location on the genome. Upon multiple hits, the best quality hit is selected, or 
upon a tie of multiple best hits, the reads are randomly distributed (the manual of 
Bowtie2 is referred to for other default behaviour).
2. Samtools [19] is used to convert and compress the SAM files into a binary BAM file.
3. Samtools is furthermore used to sort the reads in the BAM files based on the aligned 
read location in the genome, resulting in a sorted BAM file.
4. The BAM files is indexed to be able to quickly find the aligned reads based on a 
location in the genome, i.e. to be able to quickly search the BAM file. The index is 
saved as a BAI file.
5. Using the available annotation from Ensembl we can search the BAM file for reads 
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within a gene. All reads that at least partially fall within the gene exon and intron 
regions are counted once. This is done with a python script which consists of the 
combination of HTseq and pysam [20]. The output of this script is a tab separated 
file (tsv) containing the read counts per gene.
6. We used DESeq, an R-script to perform statistical analysis. DESeq is used to 
normalise the reads using a DESeq scaling factor, computed as the median of the 
ratio, for each gene, of its read count over the geometric mean across samples. Then 
variance and average of the measurement compared to the control is expressed as 
a P-value, by calculating the dispersion per gene using DESeq. The size factors as 
well as the P-values are stored in ‘tsv’ files.
7. Using scripts, similarly as in step 5, also the input files for DEXSeq can be generated. 
DEXseq requires:
• A ‘gtf’ file containing the experiment design. 
• For all samples a ‘txt’ file containing the counts obtained for the mapping data in 
the .sam files.
• Genome annotation (from Ensembl) in a ‘gff’ file. 
Scripts to obtain these files are also available in the supplement.
8. Using DEXSeq, another R-script to perform more complex statistical analysis, we 
can look at the reads within exons, and compare the variance and average per exon 
between measurement and control groups of samples. DEXSeq uses binning, where 
exons are cut into bins, based on known exon boundaries. When a read overlaps 
multiple bins, it is counted in each bin. Per bin, based on the annotation, two 
comparisons can be made, a comparison between the same exon bins in different 
samples (groups), and a comparison between an exon-bin and its neighbour exon-
bins within the same group of samples. Note that therefore DEXSeq requires at 
least two groups containing at least two samples. Based on both comparisons a 
likelihood test is performed resulting in a P-value. More details are available in 
Anders et al. 2012 [21]. The output of size factors and P-values are stored as ‘tsv’ 
files.
9. Using a script, all tsv files are combined into an excel file, available for download, 
e.g. per experiment, chromosome, per filtered results of most significant reads or 
highest ratio between measurement and control. In addition an index is built for 
fast visualization online (closed source).
Through the website of wikipathways [http://wikipathways.org/index.php/Download_
Pathways] the SVG images were downloaded on the GeneTiles server. Using Javascript, 
on the client side, within the SVG images the gene-boxes are given a background colour 
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based on a user selection, e.g. P-value or ratio. For this, the genes and or proteins 
are matched to their Ensembl references on the selected genome. In addition also 
the human pathways are searched for find homologs of genes using Ensembl biomart. 
Using these homologs, predictions of homolog pathways can be accessed, this enables 
to search a larger set of pathways contained in the human section of wikipathways. 
It should be noted that using human pathways to find information about zebrafish 




RNAseq data, containing tens of millions of reads, is mostly processed using scripts. After 
processing, a selection of reads is analysed using RNAseq viewers. Directly browsing 
processed RNAseq data is difficult due to the large dynamic range of length scales of 
reads (50 bp), exons (~200 bp), introns (~3 kb), genes (~20 kb), and chromosomes (~65 
Mb). Using a minimal size of one pixel per read, a computer screen allows only for 
~50 kb to be visible. In addition, most RNAseq viewers show introns at the same scale 
as exons, which in most experiments means that 90 percent of the visible sequence 
data does not display aligned reads. We created an online viewer, GeneTiles (www.
Genetiles.com), that does allow for browsing all the aligned reads, while eliminating 
almost completely the need for user intervention (such as zooming in). The genes in a 
chromosome are visible as tiles in a 2D array. The tile colour and intensity are a measure 
of the significance of the number of reads of experiment versus control, indicating 
changes in expression levels. When a tile is selected, the gene is loaded underneath, 
scaled to fit the width of the screen. In a schematic view all introns are shrunk to a fixed 
short length to visualize the aligned reads in a graph above the exons. To accomplish 
fast browsing, all reads are indexed on the server directly after data processing. This 
indexed data is also available for download to apply custom filtering in Excel or other 
programs. The export functions of the tiles and genes as scalable vector graphics makes 
it easy for the user to modify the final visualization for publication.
Workflow
Automated analysis of RNAseq data using GeneTiles does not need any programming 
steps anymore in a Linux environment by the user and performs directly a visualization 
of the differential expressed data, making it easier to interpret. To validate this new 
software package, RNAseq data from zebrafish bacterial infection experiments was 
obtained from Veneman et al. (2013) and used as the initial test model. All programs 
used by Veneman et al. (2013) are implemented and more visualization and export 
options are added in a server based environment (Figure 1, Supplementary file 1). 
Therefore the analysis pipeline of GeneTiles represents a combination of previously 
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described tools that have been previously shown to be useful for RNAseq analyses [22]. 
This makes it very manageable because it reduces the amount of high-end computers 
required in the research group for alignment and analysis, as all calculations are 
performed on the server. To start the analysis, the user can choose between various 
genomes that have been imported from ENSEMBL. Subsequently, the fastq files will be 
uploaded, followed by the option to analyse the data as single-end or paired-end. The 
files will be aligned automatically, after which the control or measurement treatment 
can be chosen. DESeq [23] will normalize the data, and subsequently DEXSeq [21] will 
extract differentially expressed bins that indicate differential splicing. A table containing 
the differentially expressed genes or visualizations containing tiles or individual genes 
can be exported at this point. 
With respect to the use of Bowtie2 aligner, we want to point out that it will fail to map 
reads spanning exon-exon boundaries to the genome. This problem could be solved 
using a splice aware aligner based on Bowtie2, such as Tophat2 [24]. This option will 
be included in a future version of the GeneTiles package, However Tophat2 is more 
computationally intensive, and depends in the correct predictions of splice sites. 
Therefore the analysis without the splice aware aligner as used in this paper will remain 
present. 
Different analysis methods
Considering that the RNA samples of the S. epidermidis infection experiments were 
paired-end sequenced we had the possibility to explore the added value of paired-end 
over single-end sequencing. We compared the outcome of the differential expression 
of these 2 methods as well as the difference in sample sizes as shown in Figure 2A. It can 
Figure 1: Pipeline of RNAseq data analysis. 
The diagram shows the workflow of the data 
analysis starting at the raw fastq files until the 
final visualization performed automatically 
by the GeneTiles server. The analysis pipeline 




(see legend on next page)
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be noted that a the number of differentially expressed genes does not give an estimate 
of the reliability of the data, however, considering the high quality of RNAseq data it can 
be assumed that adding an extra biological sample provides more relevant information 
than analysing a smaller group of samples by paired-end sequencing. Our data support 
this assumption since we found only a slight increase of 23% in differentially expressed 
genes when performing paired-end analysis in the 4 S. epidermidis infected samples, 
using a P-value of 0.05 as cut-off filter.
Secondly we analysed the number of differentially expressed genes with all possible 
options regarding samples sizes (Figure 2B). We found a set of 359 differentially 
expressed genes when only analysing 1 sample with a P-value of 0.05 and compared 
this large set of genes to our reference set of 203 genes (resulting from the analysis 
of paired-end sequence data of all four samples) (Figure 2C. This comparison shows a 
rather small overlap of only 23.7% (single-end) and 27.6% (paired-end). As expected, this 
overlap increases and therefore the number of false-positives decreases when adding 
more samples (Figure 2C). In order to provide a statistically more stringent analysis of 
differentially expressed genes we have also included in the GeneTiles software a tool for 
minimizing false discovery based on the algorithm of Benjamini et al. 1995 [25], using 
the implementation of DESeq. The resulting adjusted values show far more stringent 
results (Figure 2B) but generally confirm the limited value of performing paired-end 
sequencing as compared to the added value of adding more biological controls.
Comparison S. epidermidis versus M. marinum infection in zebrafish embryos
We compared the different transcriptome host responses of zebrafish embryos upon 
S. epidermidis or M. marinum yolk injection. The previous comparison as shown by 
Veneman et al. (2013) was based on a single biological replicate of M. marinum infected 
zebrafish embryos. We used this single replicate and added 5 more independent 
biological replicas which led to a total of 6 replicas of M. marinum, 4 replicas of S. 
epidermidis infected zebrafish embryos and a total of 9 replicas of non-infected 
control samples. As found before [1], S. epidermidis infection elicits a much smaller 
transcriptional host response of immune related genes compared to M. marinum 
(Figure 3). However, the total number of differentially expressed genes was increased 
since several genes that were previously not found to be significantly regulated by S. 
epidermidis where they do show a response in this analysis. Another finding is the 
high induction of genes upon M. marinum infection compared to the S. epidermidis 
(see Figure on previous page)
Figure 2: Comparing single- and paired-end RNAseq analysis. (A) The different samples sizes (n=1-4) for 
analysis are visualized. (B) The total number of differentially expressed genes with a fold change larger 
than 2 or smaller than -2 and a P-value smaller than 0.05 (solid grey bars) or an adjusted P-value smaller 
than 0.05 (patterned dark bars). (C) The light grey circles of the Venn diagrams show the total number of 
differentially expressed genes for all the samples sizes with a fold change larger than 2 or smaller than -2 
and a P-value smaller than 0.05 as shown in B, and the overlap of differentially expressed genes compared 
to the n=4 paired-end data set. The bar graphs show the overlap in percentage of these different sample 
sizes compared to the n=4 paired-end data set. 
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infected samples (Figure 3B). An explanation could be that the M. marinum bacterium 
is a natural fish pathogen, and therefore is better recognized as intruder. S. epidermidis 
is in large quantities also pathogenic for fish, however, since it is not a natural pathogen 
it could very well be that it does not get recognized as well as M. marinum. For instance, 
we now observe a high induction of the leptin b gene (lepb) upon infection with S. 
epidermidis (Figure 4). In this case the difference with the previous study is caused by 
errors in the automated annotation of probes in the micro-array used in Veneman et al. 
(2013) which was used as bench mark for the RNAseq analysis. The high expression of 
lepb found in M. marinum infected samples is in line with the results earlier described 
by Wieland et al. 2005 [26], where they found a higher mycobacterial load in the lungs 
of leptin-deficient ob/ob mice.
(see Figure on previous page)
Figure 3: An overview of differentially expressed genes. (A) The GeneTiles output shows a much larger 
set of genes with a P-value smaller than 0.05 with the M. marinum infected samples compared to the S. 
epidermidis infected samples. Each tile visualizes one gene, sorted on P-value. The colour and intensity 
are a function of the ratio between measurement and control samples. (B) Comparing the data from 3A is 
shown in the Venn diagrams on the left and the overlaps in white digits are shown in a quantitative manner 
in the bar graph on the right.
Figure 4: Lepb as highest induced gene. For both S. epidermidis O-47 (fc: 36, P-value: 4.99x10-6) and M. 




Another feature in the GeneTiles software is the integration of the DEXSeq analysis 
tool [21], which allows searching for genes that are differentially spliced. The analysis 
strategy of differential splicing is schematically shown in Figure 5A, with an example 
that shows that 1 of 4 exons is spliced out from a pre-mRNA to form the mature mRNA. 
With both the S. epidermidis and M. marinum infection data set we found glucagon a 
(gcga) as top candidate to be differentially spliced with large enrichment of two 5’ exons 
(Figure 5B), which are indicated by the dark blue bars underneath the representing 
exons. Supporting this finding, the pro-glucagon gene has been described before as 
being differentially spliced into multiple peptides in teleost fish [27]. 
(see legend on next page)
105
5
We also demonstrate that GeneTiles can quickly point out false negative results based 
on DEXSeq as a result of ambiguous ENSEMBL annotations. For instance in our analysis 
of infection markers granulin antisense (grnas) appeared as a candidate for differential 
splicing. However, the actual differential expression found of grnas occurs from a fusion 
of two genes, granulin 1 (grn1) and granulin 2 (grn2), which are located at this same 
position as shown in Figure 6. 
(See Figure on previous page)
Figure 5: Finding differentially spliced genes. (A) Schematic view of the principal of differential splicing, 
where two different mRNAs are formed from one gene. (B) For both the S. epidermidis (fc: 1.17, P-value 
4.62x10-1) and M. marinum (fc: 4.70, P-value 2.06x10-10) infected samples glucagon a (gcga) was found to 
be differentially spliced as shown by the dark blue bar under the left exon. The screenshot of the GeneTiles 
visualization demonstrates a schematic view, where introns are compressed to allow for more space 
for visualization of reads on exons. The gradient-blue bar on the right indicates the P-value predicting 
differential splicing. The bottom image is a gene representation from ENSEMBL.
Figure 6: False discovery. The differential splicing indicated by the dark blue bars at exon 2 and 4 from 
grnas proved to be incorrect. The differential expression found indicated by the 4 boxes at grnas (fc: 1.87, 
P-value 3.05x10-3) derived from grn1 (fc: 1.57, P-value 1.80x10-2) and grn2 (fc: 3.33, P-value 2.23x10-3). 
The screenshot of the GeneTiles visualization demonstrates a non-schematic view, where introns are not 
compressed showing the actual length of the introns and exons. The gradient-blue bar indicates the P-value 
predicting differential splicing. The bottom image is a gene representation from ENSEMBL.
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Comparing different host infection models
To date, we have only found 1 publication in PubMed describing RNAseq analysis of 
the host after a bacterial infection in vivo other than in zebrafish [15]. The data of 
Scholey et al. 2013 [15], describing bovine digital dermatitis (BDD, an infectious foot 
disease) was used to compare the host response in the cow and zebrafish. The raw 
data with accession number GSE41732 was obtained from the GEO database and 
analysed with the GeneTiles software package. Comparing the differential expression 
data from Scholey et al. 2013 [15], we could not validate all transcripts, since 23% of 
the transcripts are retired and are not available anymore, due to the updated version of 
the Bos taurus 4.0 ENSEMBL annotation to the COW UMD3.1 ENSEMBL annotation. All 
other transcripts could be validated.
(see legend on next page)
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Both zebrafish and bovine gene identifiers were linked to the human orthologs using 
the ENSEMBL database. The results show that 61% of the zebrafish genes and 95% 
of the bovine genes could be translated to human orthologs; a comparison of the 
differentially expressed gene sets in both disease models (P-value < 0.05) is shown in 
the Venn diagrams in Figure 7. Gene ontology (GO) [28, 29] analysis on the overlapping 
set of differentially expressed genes between the cow and zebrafish showed that the 
differentially expressed genes are categorized in multiple response processes (Figure 
7). The group of up-regulated overlapping genes between BDD, M. marinum and S. 
epidermidis infection includes the following genes; prostaglandin-endoperoxide 
synthase (PTGS2), cytochrome P450 family 24 subfamily A polypeptide 1 (CYP24A1), 
oncostatin M receptor (OSMR), Optineurin (OPTN), EPH receptor A2 (EPHA2), signal 
transducing adaptor family member 2 (STAP2), stathmin-like 4 (STMN4), LIM domain 
and actin binding 1 (LIMA1), interleukin 1, beta (IL1b), solute carrier family 3 (amino 
acid transporter heavy chain), member 2 (SLC3A2) and interleukin 1 receptor accessory 
protein (IL1RAP). As expected, most of these genes are related to the immune system 
such as OPTN which can activate Fas-ligand pathways to induce apoptosis or anti-
inflammatory responses [30], and IL1B that is a well-known cytokine produced by 
activated macrophages, which then can indirectly activate PTGS2 that also is significantly 
expressed [31]. The IL1RAP is essential for signal transduction of IL1 in order to induce 
proinflammatory proteins upon infection [32].
Pathway analysis
The visualization is not only limited to the coloured tiles as described above, but can 
also be used for functional analysis using WikiPathways [33]. With 96 zebrafish and 267 
human pathways at the moment implemented in the software package this allows the 
user a fast overview of differential expression in biological networks. An example is given 
in Figure 8, where the Toll-like receptor signalling pathway is showing the differential 
expression data of M. marinum infected embryos using the pathway we submitted to 
WikiPathways that has been accepted in the curated collection.
(See Figure on previous page)
Figure 7: Overlap with other host pathogen RNAseq experiments. The Venn diagrams show the number of 
human orthologs of differentially expressed (fc: >2 or <-2 and P-value <0.05) genes from the Bovine digital 
dermatitis, M. marinum E11 and S. epidermidis O-47 infection data. The gene ontology analysis [28, 29] is 
based on the overlapping groups indicated by the green and magenta drops.
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Lepb as highest induced gene
As mentioned earlier, we found lepb as highest induced gene upon infection with S. 
epidermidis and M. marinum. Although leptin has been studied over decades for its 
function in controlling fat balance via brain signalling, its function in innate immune 
responses has only recently been discovered [34, 35]. For instance, it was shown to be 
an important factor in mucosal immunity; however, little is known about the underlying 
mechanisms. For that reason, we designed a morpholino to knock down the function of 
lepb in embryos. At a concentration of 0.5mM we did not found any observable phenotype 
in development. Combining the lepb knock down with the injection of M. marinum 
E11 suggested that loss of lepb leads to an increase of the bacterial burden (Figure 9), 
indicating that lepb could have a role during infection. Since leptin has been described 
to be involved in metabolic processes and the wasting syndrome [36], we performed 
liquid chromatography mass spectrometry (LC-MS)on 5 day old lepb morphants versus 
wild type control embryos, each with and without M. marinum infection. We used a 
reference set of wasting syndrome associated metabolites (R. Marín-Juez, unpublished 
results) and found 7 metabolites not influenced by the M. marinum infection in the lepb 
knockdown embryos (Figure 10). This indicates that there could be a cross regulation 
between the nutritional status and immune response against M. marinum. Based on 
these results it could very well be that weight loss due to tuberculosis in humans could 
be linked to the high levels of lepb, as a result of the infection as illustrated in Figure 
11. This might be the result of the role of leptin in suppressing appetite or a hitherto 
undiscovered other function of leptin in metabolic control. However, there are some 
(See Figure on previous page)
Figure 8: Toll-like receptor pathway showing M. marium expression data. RNAseq expression data is 
shown of M. marinum E11 infected zebrafish at 5 dpi. The green and magenta boxes show differential 
expression respectively up- and down-regulation (fc >2 or <-2) with a P-value smaller than 0.05. The genes 
with an asterisk are discontinued in current databases, the white boxes could not be identified and the grey 
boxes did not meet the expression criteria.
Figure 9: The lepb morphants show an 
increased bacterial burden compared to 
the wild type infected embryos at 2 and 
3 dpi. Analysis was performed using the 
COPAS XL flow cytometer. The asterisk 




papers describing that leptin is not the missing link between the immune response 
against TB and weight loss [37-39]. For example Schwenk et al. (2003) used in their 
study heparinized blood samples from humans with pulmonary TB and did not find a 
correlation of high leptin levels and progression of TB. However, plasma concentrations 
may not always reflect the biological activity of compounds such as leptin and therefore 
do not represent the whole systemic situation. This means that our approach of using a 
whole model organism could still indicate new networks between the function of leptin 
in the context of a TB infection that are also relevant to the human situation.
Figure 10: Bar graphs showing 7 wasting metabolites differentially changes in lepb morphants with or 
without M. marinum infection. The asterisk represent P-values obtained by a student T-test; *P<0.05, 
**P<0.01, ***P<0.001 and ****P<0.0001. n=8
Figure 11: Model of the potential link between 
leptin production and TB progression. Under 
normal circumstances leptin regulates appetite 
and prevents overnutrition. Due to overnutrition 
leptin resistance can occur, which then can lead 
to uncontrolled appetite. However, leptin levels 
are also increased upon TB infection, which in 




The described toolbox for RNAseq data analysis offers two different levels of support in 
an integrative setting. First, the software combines several programs needed for open 
source RNAseq analysis such as Bowtie2, Samtools, the ‘R’ statistical package, DESeq, 
DEXSeq, HTSeq and pysam. These programs are placed in a pipeline (script) that runs 
these programs in the required order, with correct in- and output settings. Secondly, the 
processed data is visualized in a user friendly way and made available for export with a 
choice of quantitative settings.
The advantages and ease of use of this combined toolbox is demonstrated by analysis of 
previously published RNAseq datasets from zebrafish and cow infectious disease models, 
as well as new RNAseq data of a zebrafish mycobacterial infection experiments. This 
resulted in a highly confident innate marker set for systemic innate immune response to 
infection by pathogenic and non-pathogenic bacterial species in zebrafish. Furthermore, 
the data is viewable in a pathway view using the pathways stored at WikiPathways. In 
this way it was also possible to quickly determine the effect of the number of replicates 
and the evaluation of potential false positive results, as is the case for the analysis of 
differential splicing using the DEXSeq algorithm. Comparing our experiences with our 
previous analyses [1] and the re-analyses performed here we can estimate that we 
have saved several months of working time while obtaining far superior output files 
that could be rapidly compared to new RNAseq data sets also from other organisms. 
The data analysed in this study is available at the GeneTiles website for further analysis 
and as demonstration material. This makes it possible to rapidly evaluate new immune 
markers in the datasets described in this paper but also can be used to identify new 
markers based on other search criteria such as the discovery of the lepb induction after 
infection, which is currently under further investigation.
Availability and requirements
The analysis is open source and available for download, as well as offered as 
supplementary material. All visualization images are also available for download on the 
demo page of http://www.genetiles.com. The analysis pipeline, including the source 
and a complete script to run the same analysis locally is available for download. It is 
offered together with the open demo for everyone, and it is possible to apply small 
changes locally to change the analysis or to change the input files.
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Biomaterial-associated infection is a major problem in modern medicine. The 
presence of foreign body materials such as artificial hips or intravenous needles can in 
combination with the normally innocent skin bacterium, Staphylococcus epidermidis 
cause infections that are difficult to treat. To test and develop new compositions that 
could be used as biomaterials we developed a screening method. Here we report the 
outcome of a variety of nanometer and micrometer sized biomaterials injected into the 
zebrafish embryos. We found a size depended outcome of the polystyrene biomaterial 
distribution throughout the embryo. These results could hopefully contribute to the 
early stage of development of biocompatible materials for modern medicine.
Introduction
Thanks to modern medicine, the past decades people have a longer life expectation 
and their physical condition can be improved up to old age, since it is easier to replace 
body parts such bones or cartilage. However, the risk of the accompanying surgical 
treatments lead to a great chance of infection due to the implantation of the used 
biomaterial/biomedical devices such as an artificial hips, intravenous needles or 
catheters. These biomaterial-associated infections (BAI) are mainly caused by the skin 
bacterium Staphylococcus epidermidis [1-4]. This means that there is a great demand 
for biomaterials and medical devices that are biocompatible in such a way that it does 
not get rejected by the human body but also does not induce infections.
In previous studies we already showed that the zebrafish embryo is a versatile model 
to study the pathogenesis of S. epidermidis [5, 6]. The use of zebrafish larvae as whole 
vertebrate animal model in modern research has been well established. The larvae 
have great in vivo imaging potential due to their transparency and the large amount 
of transgenic strains expressing fluorescent proteins [7-9]. Secondly they are very well 
suited for high-throughput screening since zebrafish are relatively cheap to house, the 
eggs can be obtained in large amounts in a single time, and solutions containing DNA, 
RNA, morpholinos and pathogens can be introduced robotically [10, 11]. Furthermore, 
the analysis of these injected embryos can be followed over time using automated 
screening methods [5]. All these advantages have led to the fact that many human 
diseases such as tuberculosis, cancer, and cardiovascular defects have been modelled 
using zebrafish larvae [12-20]. 
In order to develop a screening model for BAI using zebrafish we report in this paper 
the outcome of distribution of biomaterials after injection. For this we used a set of 
fluorescently labelled polystyrene particles with a diameter ranging from 15 micrometer 
to 70 nanometer. Our first strategy was to inject particles as large as possible, so that 
these would not get phagocytized, but still be small enough to be injected easily using 
glass micro capillaries. The second strategy was to inject nanometer sized particles, 
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since these will probably spread easier due to their phagocytosis by motile immune 
cells, and could therefore provide more details about the distribution pattern of how 
injected agents would behave. We mainly chose the yolk of eggs between the 16 and 
256 cell stage as injection site, so results would be comparable with earlier reports of 
injection of S. epidermidis into the yolk. Secondly this method can easily be automated 
for future experiments or large high-throughput screens.
Material and methods
Zebrafish husbandry
Zebrafish were handled in compliance with animal welfare regulations and maintained 
according to standard protocols (http://ZFIN.org). Embryos were grown at 28°C in egg 
water (60 μg/ml Instant ocean sea salt, Sera Marin). The egg water was refreshed every 
day.
Experimental design
Injections were performed using mixed egg clutches from the Tg(bactin:Hras-EGFP 
VU119) [21] strain. For yolk injections: eggs were staged between 16 and 128 cell stage by 
morphological criteria, and injected into the yolk with 1 nl of 4% polyvinylpyrrolidone40 
(PVP40) containing 5 mg/ml nanometer or micrometer particles (see table 1). For tail 
muscle injection: 2 and 3 day old larvae were staged by morphological criteria and 
anaesthetized (0.02% buffered 3-aminobenzoic acid ethyl ester (Tricaine, Sigma) in 
egg water). Larvae were injected into the tail muscle [22] with approximately 1-10 nl 
containing one particle. Injections were controlled using a Leica M50 stereomicroscope 
together with a FemtoJet micro-injector (Eppendorf) and a micromanipulator with 
pulled and bevelled micro capillary needles.
Size Composition Fluorescence dye Manufacture Reference number 
70 nm Polystyrene Nile red Corpuscular inc. (USA) 103125-05 
250 nm Polystyrene Nile red Corpuscular inc. (USA) 103127-05 
2.2 µm Polystyrene Nile red Corpuscular inc. (USA) 103235-05 
4.2 µm Polystyrene Nile red Corpuscular inc. (USA) 103129-05 
9.9 µm Polystyrene Nile red Corpuscular inc. (USA) 103245-05 
15 µm Polystyrene Nile red Corpuscular inc. (USA) 103251-05 
 
Table 1: commercial available nanometer and micrometer sized particles as used in the experiments. nm= 
nanometer, µm= micrometer
Microscopy
Embryos were examined and imaged daily using a fluorescence stereo microscope (MZ 
205 FA, Leica). Embryos were kept under anaesthesia (0.02% buffered 3-aminobenzoic 
acid ethyl ester (Tricaine, Sigma) in egg water) during imaging. The image processing 




We used a set of polystyrene particles as proof of principle for studying the distribution 
of injected biomaterials into embryos. These polystyrene particles are chosen as 
they are commercially available in a monodispersed form in many different sizes. 
Earlier biomaterial injection experiments with materials that are more related to 
medical devices such as titanium, poly(lactic-co-glycolic acid) or polycaprolactone 
led to difficulties. These particles are irregular in shape as well size, with as result 
clogging of the glass micro capillaries and inconsistent outcomes. However, with the 
monodispersed polystyrene particles these problems did not occur. Using a 4% PVP40 
solution as a carrier made it possible to inject polystyrene particles into the embryonic 
yolk because the viscosity of the solvent prevented the particles from flowing out after 
injection. The visualization of the distribution of particles was facilitated by the use 
of the Tg(bactin:Hras-EGFP VU119) strain which expresses membrane-targeted GFP as 
shown in Figure 1 and 2. Following injection into the yolk of 16-128 cell stage embryos, 
we observed a difference in the distribution of biomaterials of various sizes throughout 
the body of the embryo (Figure 3). The nanometer sized biomaterials spread more 
compared to the micrometer sized biomaterials. One possible explanation could be that 
the concentration of particles per nanoliter of the small particles was higher since all 
suspensions were diluted to a 5 mg/ml concentration and the same volume of materials 
was injected. Another explanation could be that there is indeed a size dependent factor, 
which makes that the smaller beads spread easier than larger sized beads. This is in 
line with earlier findings of Desai et al. (1996 & 1997) [24, 25], who also found that 
nanometer sized particles had a higher uptake in rat tissue and in vitro compared to 
the micrometer sized particles. We did find that the smaller sized particles (70 & 250 
nm) accumulate around the heart region at 3 to 4 days post injection (dpi) (Figure 2) 
from where they probably distribute throughout the body. In a few experiments we 
found a very small number of embryos with larger sized beads (≥ 9.9 µm) throughout 
the body. Since the embryos did not show any signs of distributed particles yet at 1 day 
post fertilization (dpf), we can rule out the possibility that the yolk-injected particles 
were spread as a result of uptake by cells during the first hours of development, as in 
the case with early RNA or DNA injections before the 16 cell stage. It is also unlikely that 
these large particles were distributed at later developmental stages via the vasculature, 
since the maximum diameter of the vasculature is also around 10 µm in diameter. We 
performed a whole mount L-plastin immunohistochemistry [26] on larvae injected 
with the larger sized particles (≥ 9.9 µm) to check for possible uptake by leukocytes at 
later stages from 2 until 5 dpi, but we could not colocalize the particles with leukocytes 
throughout the body (data not shown). 
Even though the percentage of embryos showing a distribution of particles through 
the body is low, it indicates that it is possible for such materials being taken up into the 
body of the embryo after injection into the yolk. This has implications for the results 
of earlier reports [5, 6, 10, 11] on spreading of bacteria and human cancer cells after 
121
6
being injected into the early embryonic yolk since it indicates that distribution could 
be driven by unknown aspecific processes from the host. We are hoping to unravel the 
mechanism(s) of such aspecific transport from yolk to body in future research.
All previously described experiments were based on the yolk injection method. We also 
performed injections of beads in the tail muscle of 2 and 3 day old larvae, which mimics 
the implantation of an artificial implant in human chirurgical applications, since the 
implantation is performed directly into tissue. However, when using the 9.9 µm sized 
particles these injections proved to be very labour intensive, and did not result in the 
biomaterial to remain in the same place after injection (data not shown). In almost all 
cases the particles were pushed out of the tissue while injecting. Even when the particle 
would stay at the implantation side, a considerable amount of tissue damage occurred.
Figure 1: Representative bright field /fluorescence overlay images showing migration of Nile red 
fluorescence particles throughout the Tg(bactin:Hras-EGFP VU119) embryos over a 5 day period. The x 
axis shows the different sizes of particles injected and the y axis shows the time period from 1 until 5 dpi.
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Figure 2: Detailed images of Tg(bactin:Hras-EGFP VU119) larvae injected with particles. The yellow boxes 
show the particles close to the heart region or already migrated away from the yolk injection side.
Figure 3: Quantification of distributed particles. The graph shows the percentage of embryos with nano or 




We found that there was a difference based on size in distribution of biomaterials. The 
preferable larger sized biomaterials (≥ 9.9 µm) migrated less than the smaller sized 
biomaterials (≤ 2.2 µm). The location where they accumulate still remains unknown, 
however if they spread, such as the smaller particles (≥ 2.2 µm), it probably starts at 
the heart region from where they distribute out inside the body. The mechanism of 
how particles spread also remains unknown, however we think that the larger (≥ 9.9 
µm) particles do not get taken up by leucocytes and there is no evidence for spreading 
via the vasculature. Nevertheless we hope to find the mechanisms/processes that are 
involved during the migration of these particles in the future. 
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General discussion and summary
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Thanks to all the great medical inventions in the last couple of centuries the life 
expectancy of the human population is significantly increasing. By the year 2050 
twenty-two percent of the human population will be older than the age of 60. This puts 
great pressure on the health care, since this group will most likely need medical care 
at a certain point due to cancer, diabetes, osteoporosis, heart diseases or any other 
kind of age-related disease. However, there can still be great improvements achieved 
in the field of medical instruments and implants. Although there are already many 
implants or medical tools available, there is still a risk of infection, related to these 
biomaterials. One of the main priorities during development is the functionality of the 
material, such as a titanium hip that lasts a long time. However, biocompatibility is also 
a factor of great importance. Testing biocompatibility of new materials in early stages 
of development could save time and money. However choosing the right model for the 
research question can be difficult. Does the data from cell and tissues culture provide 
sufficient information or does it lack the complex networks that you can find in animal 
models, and which animal represents the human situation the best? At the same time 
the requirements for the laboratories and facilities are also playing a very important 
role, since some pathogens or animals can be examined in biosafety level 1 laboratories 
where other are restricted to biosafety level 3 or 4 laboratories. 
Development and optimization of high-throughput zebrafish techniques
The work in this thesis uses zebrafish larvae as a test organism for studying various 
infectious diseases. Most of the advantages of using the zebrafish larvae as a model 
are already discussed in detail in the previous chapters. One of these advantages and 
the focus of this thesis is that zebrafish eggs and larvae are ideal for high-throughput 
screening. We analysed which developmental stage is optimal for spreading of bacterial 
though the body after yolk injection with 2 types of bacteria, namely Staphylococcus 
epidermidis and Mycobacterium marinum. We also compared the outcome with other 
injection methods like injecting into the caudal vein at 1 day post fertilization (dpf). We 
determined that injection into the yolk with S. epidermidis and M. marinum between 
the 16-128 cell stage results in reproducible infections with spreading of the bacteria 
into the tissues of the embryo at later stages. In contrast, injection before the 16 cell 
stage leads to a high mortality and injecting after the 128 cell stage does not lead to a 
representative infection. The more virulent M. marinum M strain does not even give a 
representative infection after the 64 cell stage (chapter 3).
The early developing zebrafish egg is ideal to automatically inject into the yolk, and 
we showed that this could be performed with RNA, DNA, bacteria or cancer cells 
(chapter 2). The automated micro-injector allowed us to inject up to 2000 eggs per 
hour in a consistent manner into the yolk of a developing zebrafish egg. This kind of 
specifications cannot be reproduced with manual injection techniques. Using this kind 
of automated micro-injector yields therefore a strongly increased number of samples 
that can be used for compound screening or testing other biological questions, and 
with that reduces valuable research time. 
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However handling these amounts of samples also requires fast and efficient analysis 
techniques. We made use of a model of flow-cytometry that can handle extraordinary 
large particle sizes (called COPAS XL), which could analyse and sort large amounts of 
infected larvae (2000/30min), without harming the larvae. Therefore this analysis 
could be performed daily to monitor the fluorescence signal of the bacterial burden 
in large groups of infected larvae (chapter 4). The only drawback of performing such 
flow-cytometry is the low resolution. However, to overcome this problem we also 
implemented a medium throughput, high resolution method. Therefore, we used the 
Vertebrate Automated Screening Technique (VAST BioImager), that automatically loads 
and positions the larvae to predefined settings. The imaging was performed using a 
confocal laser scanning microscope (CLSM) with an additional colour camera (chapter 
3).
Using this high-throughput pipeline we were able to understand the pathogenesis 
of S. epidermidis in zebrafish larvae better. We performed intensive microscopy, flow 
cytometry and transcriptome analysis, on the infection process of S. epidermidis in 
zebrafish larvae. The use of the COPAS XL proved to be accurate to analyse the bacterial 
burden without homogenizing and plating the embryos. Secondly the use of micro-
array analysis led to detailed host transcriptome expression, which was replaced by 
RNA deep sequencing (RNAseq) within the project. 
Transcriptome analysis
Although the micro-array approach provides useful expression patterns of the 
transcriptome, the method of detection is rather biased. Micro-arrays use labelled 
probes for the detection which means that if a probe is not present on the chip it will 
not be found. RNAseq on the other hand counts short reads based on a reference 
genome as illustrated in Figure 1. This means that also expression of non-annotated 
sequences can be discovered and the analysis can be repeated when updated genomes 
are released. We chose to use the RNAseq analysis method using Illumina sequencing 
which is based on the sequencing of cDNA that is de novo replicated on flow cells. 
However, there are also other options available for the analysis of differential expression 
of RNA such as Ion Torrent sequencing, which also measures cDNA instead of RNA but 
on a semiconductor chip. In this technology small fragments bind to specific beads from 
where hydrogen ions will be released when a nucleotide binds to the fragment. This 
leads to changes of the pH that can be measured with a voltage meter. These changes in 
voltage can therefore be used to read the sequence. Another option that might be used 
in the near future is direct sequencing of RNA using the MinION device. This is based on 
consumable flow cells with nanopores that can sense single molecules. This little device 
with the size of a USB-stick can be used for DNA sequencing but could, theoretically, also 
be used also for RNA and protein sequencing. However, the nanopore technology is still 
under development and although it offers good perspectives for further decreasing cost 
of sequencing its suitability for direct RNA sequencing has still not been demonstrated.
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A possible draw-back of RNAseq technology is that the analysis of sequence data requires 
some dedicated bioinformatics skills that are not always available in biology institutes. 
A possible solution would be to outsource the bioinformatic analyses to companies but 
this is currently very costly. For that reason we collaborated with bioinformaticians and 
statisticians to design a platform for fast and user friendly analysis of large RNAseq data 
files. This resulted in the design of the GeneTiles software package (chapter 5), which 
combines all the programs needed for basic RNAseq analysis such as Bowtie2, Samtools, 
the ‘R’ statistical package, DESeq, DEXSeq, HTSeq and pysam. All these programs run in 
a pipeline in a server based environment, which can be accessed from every computer 
with operations systems such as Windows and Linux with an internet connection. One 
of the advantages of having the analysis run on a server is that there is no need any more 
Figure 1: The differential expression analysis methods. The left side shows the micro-array technique with 
hybridization of the probes on the chip. Only targets present on the chip be found, and due to multiple 
probes of a target to improve sensitivity, this will reduce the total amount of total targets on the chip. The 
right side shows the RNAseq technique, which uses short reads to quantify the expression levels. Therefore 
unknown sequences can be found and the analysis can be repeated with newer and updated versions of 
the reference genome. 
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for powerful computers in the laboratory. To offer a complete package that includes 
the entire analysis and direct visualization, multiple options are implemented, such as 
differential expression sorting on ratio, P-value, adjusted P-value, differential splicing 
or just chromosome view. In addition to this we also included all available biological 
pathways from Wikipathways. This allows quicker and better interpretation of the 
expression data in a more complex manner. As result of this improved RNAseq analysis 
method we found a gene that was differentially spliced under infectious conditions, 
namely glucagon a (gcga). 
Metabolic changes upon infection 
Another finding was the high induction of the leptin b (lepb) gene in RNAseq data both 
S. epidermidis and M. marinum infected embryos. This was not discovered earlier since 
the lepb probe was not present on the micro-array. The leptin hormone is normally 
produced by fat cells, which regulate the fat balance in the human body. If a person 
consumes food, a signal is given to the hypothalamus, which then regulates the 
appetite, and prevents from overeating. However, if a person continuously overeats, 
this can lead to leptin resistance. This means that the leptin signal does not arrive at the 
hypothalamus and that there is no feedback signal that prevents overeating. Therefore 
people will eat more than they need and gain weight with obesity as a result (Figure 2). 
This can in turn also lead to continuous production of too high levels of insulin leading 
to insulin resistance. Insulin resistance is the hall mark of diabetes type 2 that results in 
chronic problems in diminishing blood glucose levels (leading to hyperglycaemia), and a 
lack of conversion of glucose to glycogen in tissues. Due to the high glucose levels in the 
circulation, people will also get more susceptible to heart diseases, stroke, blindness 
and kidney failure.
Since the leptin gene is a very interesting gene which is already linked to multiple 
metabolic and immune functions, and lepb was the highest induced gene upon infection 
with M. marinum and S. epidermidis we designed a morpholino to knock down the lepb 
gene functionality in the early development of the zebrafish embryo. Preliminary results 
suggested an induced bacterial burden in the lepb morphants, which indicates that 
lepb could have a role upon a M. marinum infection in zebrafish larvae. This prompted 
us to perform mass spectrometry on these lepb morphants with and without a M. 
marinum infection versus wild type controls. We found metabolites associated with the 
wasting syndrome (R. Marín-Juez, unpublished results) to be no longer influenced by 
infection in the leptin knockdown situation. The results therefore showed that leptin is 
an important player in the wasting syndrome caused by infection. This could indicate 
that there is cross regulation between nutritional status of the host and the immune 
response against M. marinum. This could also be a possible explanation of acute weight 
loss due to TB, since appetite is supressed by high leptin levels, due to infection. At 
later stages of infection by TB bacteria one could speculate that leptin resistance in the 
hypothalamus might occur, leading to a complex situation where a return of appetite in 
combination with wasting might lead to a new stage of tuberculosis disease progression.
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Figure 2: Functions of the leptin gene. Under normal conditions leptin regulates appetite and prevents 
from overeating. When a person overeats, the adipocytes will increase and the chance of leptin resistance 
occurs. This leads to uncontrolled appetite and chances of developing diabetes type 2. Leptin is also 
increased in TB infected people, which could suppress appetite with weight loss as result. This figure is 




As described above, we developed many different injection and implantation 
techniques for biomaterial-associated infection in zebrafish larvae (chapter 6). However, 
reproducibly implanting biomaterials into zebrafish embryos appeared to be more 
difficult than expected. Injection of polystyrene beads into the tail muscle proved to be 
rather labour intensive, whereas injection into the yolk did not lead to high frequencies 
of distributed biomaterials. We did find a size dependent distribution of beads ranging 
from 70 nm to 15 µm. The smaller sized beads did distribute more than the larger 
ones. We have not found the mechanism yet that explains the distribution of these 
particles, but hope to elucidate this in future work. The implantation of beads could 
in combination with the infection model of S. epidermidis in zebrafish as described in 
chapter 3, 4 and 5, be an important addition to the already known mammalian research 
models on biomaterial-associated infection.
Conclusion
Infectious diseases are everywhere around us, and we need to keep improving our 
knowledge about our defence mechanisms and the evasion strategies of the pathogens. 
The work in this thesis describes multiple techniques that can contribute to fast 
screening methods in order to come up with new strategies against infectious diseases. 
The use of automated micro-injectors in combination with large flow cytometers 
and automated microscopy has shown added value (chapters 2, 3 & 4) for research 
questions about (opportunistic) pathogens. The collaboration between scientists of 
different research areas has proved to be very successful in the development of an easy 
to use analysis platform for the analysis of RNAseq data (chapter 5). This has led to very 
detailed description of host molecular expression patterns following infection by these 
pathogens. This could be used to gain more insight in how biomaterials behave in a 
host environment in the presence or absence of infection (chapter 6). All together this 
has led this to a variety of research methods that can be used for studies of infections 
caused by many bacteria such as S. epidermidis and M. marinum described in this thesis, 








Met alle ontwikkelingen in de laatste paar decennia is de levensverwachting van de 
mens ook erg vooruit gegaan. De verwachting is dat in het jaar 2050 tweeëntwintig 
procent van de wereldbevolking ouder is dan 60 jaar. Dit heeft natuurlijk een groot 
effect op de gezondheidszorg, gezien deze bevolkingsgroep op een moment in het 
leven medische zorg nodig zal hebben als gevolg van kanker, diabetes, osteoporose, 
hartziekten en veel andere vormen van ouderdom gerelateerde ziekten. Om de 
medische zorg die men nodig heeft te waarborgen, moeten we zorgen voor een goede 
ontwikkeling van medische instrumenten, zowel wat betreft functionaliteit als als 
biocompatibiliteit. Op dit gebied kunnen nog altijd grote verbeteringen plaatsvinden. 
Het gebruik van het juiste onderzoeksmodel is hierbij erg belangrijk. Geeft de data van 
cel- of weefselkweek genoeg informatie of schiet het tekort aan diepte in biologische 
context, welke je wel kan vinden in diermodellen? En welk model geeft de humane 
situatie het beste weer? De laboratoria en faciliteiten spelen hierbij ook een belangrijke 
rol, aangezien sommige pathogene organismen onderzocht kunnen worden in een 
biologisch veiligheidslaboratorium van niveau 1, daar waar andere alleen in biologisch 
veiligheidslaboratoria van niveau 3 of 4 onderzocht kunnen worden.
Ontwikkeling en optimalisatie van high-throughput-technieken voor zebravisonderzoek
Het werk in dit proefschrift is in het bijzonder gericht op het gebruik van embryo’s 
en larven van de zebravis als model voor verschillende infectieziekten. Een belangrijk 
voordeel en het onderwerp van dit proefschrift is het feit dat de embryo’s en larven ideaal 
zijn voor high-throughput screening. Zo hebben we bepaald welk ontwikkelingsstadium 
het beste is voor injecties in de dooier van het embryo met twee verschillende soorten 
bacteriën, namelijk Staphylococcus epidermidis en Mycobacterium marinum. We 
hebben de resultaten vergeleken met andere injectiemethoden zoals injectie via de 
ader in de staart van een embryo van 1 dag oud. We hebben aangetoond dat injectie van 
S. epidermidis en M. marinum in de dooier van embryo’s tussen het ontwikkelingsstadia 
van 16 tot 128 cellen optimaal is. Er vindt dan in latere ontwikkelingsstadia verspreiding 
van de bacteriën naar andere weefsels plaats. Injectie in een vroeger stadium leidt tot 
hoge mortaliteit en in een later stadium leidt ook niet tot een representatieve infectie. 
De meer virulente M. marinum M stam kon het beste voor het stadium van 64 cellen 
worden geïnjecteerd (hoofdstuk 3)
Aangezien de vroege ontwikkelingsstadia van zebraviseitjes ideaal zijn om automatisch 
te injecteren in de dooier, hebben we dit uitgevoerd met RNA, DNA, bacteriën of 
kankercellen (hoofdstuk 2). De automatische micro-injector is namelijk in staat om 
consistent 2000 eitjes per uur te injecteren. Deze aantallen injecties zijn niet meer 
te evenaren door middel van handmatige injecties. Door het gebruik van dit soort 
automatisering zijn we in staat om meer monsters te produceren voor bijvoorbeeld 
antibioticatesten of andere biologische vraagstellingen in minder tijd. Dit houdt in 
dat waardevolle onderzoekstijd bespaard kan worden. Echter, het onderzoeken van 
grote aantallen monsters vraagt ook om geavanceerde analysemethoden zoals flow-
cytometrie. Wij hebben gebruik gemaakt van een extra groot model flow-cytometer 
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(COPAS XL) dat in staat is om zebravislarven te analyseren en sorteren (2000/30min), 
zonder ze daarbij te beschadigen. Daarom kan deze analyse dagelijks herhaald 
worden om het fluorescente signaal van de aanwezige bacteriën in deze larven te 
meten (hoofdstuk 4). Er is echter wel één probleem bij flow-cytometrie, en dat is 
de lage resolutie. Dit probleem hebben we opgelost door gebruik te maken van een 
geautomatiseerde screeningstechniek (VAST BioImager). Daardoor zijn we in staat om 
larven automatisch te laden in een glazen capillair en te oriënteren in de gewenste 
hoek, om deze vervolgens te analyseren met een confocale laser scanning microscoop 
met extra kleurencamera (hoofdstuk 3).
Door het gebruik van deze high-throughput methode hebben we een beter begrip 
gekregen van de pathogenese van S. epidermidis in zebravislarven. We hebben hiervoor 
microscopie, flow-cytometrie en transcriptoomanalyse uitgevoerd. Door het gebruik 
van de COPAS XL hebben een snelle analyse weten uit te voeren om de hoeveelheid 
bacteriën in de larven te bepalen, zonder de larven hiervoor te moeten opofferen. 
Transcriptoomanalyse
We hebben door gebruik te maken van micro-arrays een basis gelegd voor analyse van 
transcriptoomveranderingen na een infectie in het zebravisembryo. Deze methode 
werd al snel vervangen door RNA deep sequencing. Micro-array maakt gebruik van 
gelabelde probes voor de detectie, wat betekent dat als een bepaalde probe niet 
aanwezig is ook de expressie van dit bepaalde gen niet gevonden zal kunnen worden. 
RNAseq daarentegen telt het aantal sequenties van verschillende genen gebaseerd 
op een referentiegenoom. Om die reden kunnen er ook onbekende genen gevonden 
worden, en de analyse kan altijd herhaald worden met betere en nieuwere versies van 
een referentiegenoom.
Wij hebben de keuze gemaakt voor Illumina sequencing, dat gebaseerd is op analyse 
van expressie van cDNA dat de novo gerepliceerd wordt op de flow cell. Echter, er 
zijn ook nog andere opties beschikbaar voor de expressieanalyse van RNA, zoals Ion 
Torrent sequencing, dat ook gebruik maakt van cDNA in plaats van RNA, maar dan wel 
op een semiconductorchip. Met deze methode worden kleine fragmenten gebonden 
op specifieke beads waarvan waterstofmoleculen worden los gelaten wanneer een 
nucleotide bindt. Dit leidt tot een verandering van de pH, wat door een voltagemeter 
gemeten kan worden. Deze veranderingen in voltage kunnen dus omgezet worden in een 
sequentie. Een andere optie in de toekomst zou de directe methode van RNA-sequencing 
met behulp van de MinION kunnen zijn. Deze methode is ook gebaseerd op flow cells 
met nanopores die individuele moleculen kunnen meten. Dit apparaat heeft slechts de 
grootte van een USB-stick en wordt al gebruikt voor de sequencing van DNA maar kan 
theoretisch ook gebruikt worden voor RNA of eiwitten. De nanoporetechnologie is nog 




Een nadeel van RNAseq is de complexiteit van de analyse van de data. Het vereist namelijk 
nogal wat programmeerkunde, wat niet altijd beschikbaar is in biologieinstituten. 
Een oplossing zou kunnen zijn om het door bedrijven te laten uitvoeren, maar hier 
hangt dan wel een prijs aan. Om die reden hebben wij samen met bio-informatici en 
statistici een platform ontwikkeld voor het snel en gemakkelijk analyseren dan RNAseq-
data. Het resultaat is een softwarepakket genaamd GeneTiles (hoofdstuk 5), dat alle 
programma’s zoals Bowtie2, Samtools, ‘R’ statistiek programma, DESeq, DEXSeq, HTSeq 
en pysam combineert in één programma. Aangezien GeneTiles op een server draait, 
kan het bereikt worden van alle computers met verschillende besturingssoftware zoals 
Windows of Linux met een internetconnectie. Eén van de grote voordelen van het feit 
dat GeneTiles op een server draait is dat daardoor geen snelle en dure computers in 
het laboratorium meer nodig zijn. Om een zo compleet mogelijk pakket te hebben voor 
de analyse zijn er extra opties toegevoegd voor directe visualisatie van differentiële 
expressie gebaseerd op ratio, P-waarde, gecorrigeerde P-waarde, differentiële splitsing 
of gewone chromosomen. Tevens hebben we alle beschikbare biologische pathways van 
Wikipathways toegevoegd. Daardoor kan expressiedata direct gevisualiseerd worden in 
complexe netwerken en data sneller en beter geïnterpreteerd worden. Het resultaat 
van deze nieuwe methode is de vondst van een gen dat onder infectieuze condities 
differentieel gesplitst kan worden, namelijk glucagon a (gcga). 
Metabole veranderingen als gevolg van infectie
Een andere opmerkelijke vondst is de hoge expressie van het gen voor leptine b 
(lepb) in larven geïnfecteerd met S. epidermidis en M. marinum. Dit was niet eerder 
ontdekt omdat er geen probe van lepb aanwezig was op de micro-array. Het leptine gen 
wordt onder normale condities geproduceerd door vetcellen, die de vethuishouding 
reguleren in het lichaam. Wanneer een persoon eet, wordt een signaal afgegeven naar 
de hersenen om aan te geven wanneer je vol zit. Echter, wanneer een persoon continu 
te veel eet, kan dit tot leptineresistentie leiden. Dit heeft tot gevolg dat er geen signaal 
meer is dat je waarschuwt om te stoppen met eten. Hierdoor eten men meer dan nodig 
en zal daarbij in gewicht aankomen met obesitas als resultaat. Dit kan dan leiden tot 
een continue productie van te hoge waarden van insuline, met insulineresistentie als 
gevolg. Insulineresistentie is 1 van de kenmerken van diabetes type 2 dat kan leiden tot 
chronische problemen van het verlagen van het bloedsuikerspiegel, en een tekort aan 
glucose omzetting tot glycogeen. Als gevolg van deze continue hoge bloedsuikerspiegel 
is men meer vatbaar voor hartziekten, beroertes, blindheid en nieruitval.
Aangezien leptine al erg interessant was vanwege verschillende functies in het 
metabolisme en het immuunsysteem en omdat lepb het meest geïnduceerde gen was na 
infectie met M. marinum en S. epidermidis, hebben we een morpholino ontworpen om 
de functie van lepb te onderdrukken (knockdown) gedurende de vroege ontwikkeling 
van een zebravisembryo. De resultaten wezen op een verhoogde hoeveelheid M. 
marinum-bacteriën in de knockdown-embryo’s. Dit zou kunnen betekenen dat lepb 
een belangrijke rol heeft in het infectieproces van M. marinum in zebravislarven. 
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Daarom hebben we massaspectrometrie uitgevoerd op knockdown-embryo’s en wild 
type embryos’s, beide met en zonder infectie. We vonden metabolieten geassocieerd 
met het wasting syndroom (R. Marín-Juez, ongepubliceerde data) niet langer meer 
beïnvloed na infectie in de leptine knockdown-embryo’s. De resultaten geven aan dat 
leptine een belangrijke factor is gedurende het wasting syndroom als gevolg van een 
infectie. Dit kan een indicatie zijn dat een verband is tussen de voedingsbalans en de 
immuunrespons tegen M. marinum. Tevens zou dit een mogelijke verklaring zijn voor 
gewichtsverlies als gevolg van tuberculose, omdat de eetlust is onderdrukt door hoge 
concentraties leptine als gevolg van de infectie. In latere stadia van een tuberculose 
infectie, zou men kunnen speculeren dat leptineresistentie in de hypothalamus kan 
optreden, met als gevolg een complexe situatie waarbij de terugkeer van de eetlust in 
combinatie met het wasting syndroom, een nieuw stadium van de tuberculose infectie 
kan vormen.
Biomateriaal-geassocieerde infecties
Zoals eerder beschreven hebben we veel verschillende injectie- en implantatietechnieken 
ontwikkeld voor biomateriaal-geassocieerde infecties. Echter het reproduceerbaar 
implanteren van biomaterialen in zebravislarven bleek moeilijker dan gedacht (hoofdstuk 
6). Injectie van polystyreenpartikels in de staartspier bleek erg arbeidsintensief en 
injectie in de dooier resulteerde slechts in een geringe verspreiding door het lichaam. 
Desondanks hebben we aangetoond dat de diameter van de biomaterialen een effect 
heeft op de verspreiding. De kleinere partikels verspreiden namelijk meer dan de 
grotere partikels. Het mechanisme dat de verspreiding kan verklaren hebben we nog 
niet ontdekt, maar hopen we op korte termijn te kunnen ontrafelen. De implantatie 
van biomaterialen in combinatie met de gedetailleerde pathogenese van S. epidermidis 
zoals beschreven in hoofdstuk 3, 4 en 5, zou een perfecte toevoeging kunnen zijn voor 
reeds bekende zoogdiermodellen voor biomateriaal-geassocieerde infecties.
Conclusie
Infectieziekten zijn overal om ons heen en daarom moeten we onze kennis over 
virulentiefactoren en afweermechanismen blijven ontwikkelen. Het werk beschreven 
in dit proefschrift gaat over verschillende technieken die bij kunnen dragen aan 
snelle screeningsmethoden met het doel om nieuwe strategieën te ontwikkelen 
tegen infectieziekten. Geautomatiseerde micro-injectoren in combinatie met 
grote flow-cytometers hebben hun toegevoegde waarde laten zien (hoofdstuk 2, 
3 & 4) voor onderzoeksvragen met betrekking tot (opportunistische) pathogenen. 
Samenwerkingsverbanden tussen verschillende onderzoeksgroepen bleken erg 
succesvol met als resultaat de ontwikkeling van een gemakkelijk te gebruiken 
analyseplatform voor RNAseq-data (hoofdstuk 5). Dit had veel gedetailleerde 
expressieprofielen van deze pathogenen in de gastheer tot resultaat. Deze aanpak kan 
ook meer inzicht geven in hoe biomaterialen zich gedragen in een gastheeromgeving 
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in aanwezigheid of afwezigheid van een infectie (hoofdstuk 6). Alles bij elkaar heeft 
dit onderzoek geresulteerd in verschillende onderzoekmodellen voor de studie van 
infecties veroorzaakt door bacteriën zoals S. epidermidis en M. marinum beschreven in 
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